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ABSTRACT
DETERMINED WELLNESS: THE INFLUENCE OF MENTAL ILLNESS MODELS
UPON TREATMENT OUTCOME EXPECTANCIES AND TREATMENT
ENGAGEMENT

May 2017

Francisco I. Surace, BA, Florida International University
M.A., University of Massachusetts Boston
Ph.D., University of Massachusetts Boston

Directed by Professor by Heidi M. Levitt

Multiple campaigns geared towards reducing public and self-stigma associated
with depression, and increasing help-seeking behaviors have been launched in the past
two decades. There has been an increase in promoting psychoeducation on the biological
bases of mental illness. Recent international studies have documented that this increase
in public knowledge has not reduced stigma. Indeed, growing evidence suggests that
biological models, in comparison to other causal models of mental illness, decrease
people’s sense of self-efficacy and self-control, and decrease positive expectancies of
treatments and prognosis–among those with and without mental illness. Individuals who
have encounter health services, however, hold more positive and realistic expectancies of
treatments than those who have not. Therefore, adequate education about mental illness
and its treatment by providers is key at improving treatment expectancies and
engagement. Results documented that biological explanations increased biological causes

iv

and reduced endorsement of social and psychological causes, led to decreases in
endorsement of non-professional help, and increased endorsement of positive outcome
expectancies for attending psychotherapy. Second, psychosocial explanations increased
endorsement of social causes, increased likelihood in engaging in psychotherapy, and
increased endorsement of positive outcome expectancies for attending psychotherapy and
taking psychiatric medications. Third, biopsychosocial conditions produced increases in
endorsement of taking psychiatric medications and increased endorsement of positive
outcome expectancies for attending psychotherapy. Fourth, control condition increased
endorsement of taking psychiatric medications and increased endorsement of positive
outcome expectancies for attending psychotherapy. There was no interaction effect of
self-stigma for attending psychotherapy or taking psychiatric medications; however, main
effects of time suggest that self-stigma for attending psychotherapy and taking
psychiatric medication reduced across time. Moreover, after treatment education there
were no interactions between time and condition. However, main effects of time showed
increased likelihood taking psychiatric medications and decreased likelihood seeking
non-professional help, increases positive outcome expectancies of treatment, and
decrease in self-stigma for seeking treatment. The findings of the current study suggest
that biologically based psychoeducation of depression may hinder patients. It is most
optimal to include and highlight the effect of psychosocial factors of depression through
psychoeducation campaigns.
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CHAPTER 1
INTRODUCTION
It is estimated that around 25% people in the United States (US) have been
diagnosed with a mental illness and that 50% of adults will develop at least one
psychological disorder in their lifetime. The economic burden of mental illness and its
medical consequences is substantial, costing up to $300 billion (CDC, 2013). Depression,
one of most common psychological disorders, has been rising from 6.6% to 9% with
adults meeting diagnosis from 2006 to 2008 (CDC, 2013). There are multiple treatments
for depression ranging from lifestyle changes to psychotherapy and pharmacotherapy;
however, less than 40% of people with a mental illness actually receive any treatment at
all (Kessler et al., 2001).
Financial and situational barriers have been cited as factors that influence
treatment engagement and help-seeking (Kessler et al., 2001). However, changes in U.S.
policy, such as the Affordable Health Care Act and the Mental Health Parity Act,
promised hope for those who lack access to mental health services (Beronio, Glied, &
Frank, 2014). As the health care system continues to change, psychological and
attitudinal barriers to obtaining services may become more apparent. Currently, negative
beliefs that psychotherapy is for weak people, that individuals should solve problems on
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their own, and that antidepressants lead to addiction continue to interfere with seeking
help (Clement et al., 2014; Tucker et al., 2013).
In many instances, these attitudinal barriers do not reflect the reality of the costeffectiveness and efficacy of currently available psychiatric and psychological treatments.
A US-based meta-analysis has shown that both, psychotherapy and psychiatric
medications, are helpful to individuals diagnosed with depression and anxiety (e.g.
Roshanaei-Moghaddam et al., 2011). Moreover, recent cost-effectiveness meta-analysis
in the United Kingdom (UK) has documented that cognitive therapy (CT) and
combination therapy (pharmacotherapy and CT) had better outcomes and were more
cost-effective than pharmacotherapy alone (Koeser, Donisi, Goldberg, & McCrone,
2015). Beyond monetary restrictions, the efficacy of pharmacological and
psychotherapeutic treatments still remains in question. For instance, a second metaanalysis completed in the UK documented that pharmacotherapy effects for moderate to
severe depression may be attributed to placebo effects rather than responsiveness to
actual medication (Kirsch et al., 2008). Whether reduction in psychiatric symptoms is due
to psychotherapy or placebo effects of pharmacotherapy is still contentiously debated.
Internationally, the debate has resulted in contradictory guidelines related to
recommended treatments of mild depression (Cosgrove, Bursztajn, Erlich, Wheeler, &
Shaughnessy, 2013), with many countries removing the prescription of medication.
Therefore, findings from these meta-analyses have implications for health and
mental health providers as these professionals are responsible for providing education
about and referrals to adequate evidence based treatments. In most instances the burden
has fallen on primary care physicians (PCPs) to make decisions about depression care
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(Young, 2008). However, their diagnostic skills and treatment recommendations have
come into question in the past few years as mixed findings suggest that PCPs overdiagnose or undertreat depression in their patients (Simon, Fleck, Lucas, & Bushnell,
2004).
In one study, Lawrence and colleagues (2012) observed treatment
recommendations practices of PCPs (n = 896) and psychiatrists (n = 312) for a 56 year
old fictional vignette character seeking help for symptoms of mild depression. Their
study recorded that psychiatrist (68%) and PCPs (56%) were “very likely” to prescribe
antidepressants for mild depression. In addition, only 12% of the PCPs and 44% of the
psychiatrist would provide counseling to the mildly depressed vignette character, and
only half of the psychiatrist and PCPs were “very likely” to give a referral to a
psychologist or counselor. Overall, these finding shed light on the treatment
recommendation tendencies of this particular group of medical professionals. While the
study could not account for patients’ treatment preferences, studies have shown that PCPs
tend to not engage with their patients on shared decision making for depression care (e.g.
Young, 2008).
Unfortunately, these treatment recommendation trends fly in the face of empirical
findings, professional guidelines, contemporary models of recovery, and ethical protocols
that suggest that pharmacological treatment may not be the best intervention for all
depressive illnesses. For instance, the American Psychiatric Association (APA, 2010)
suggests that a combination of psychosocial and pharmacotherapies are helpful across
levels of severity for depression, while the National Institute for Health and Clinical
Excellence in the UK advises against prescribing medication to mildly depressed clients
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(BPS, 2010). Also, the National Mental Health Association (NIMH, 2011) suggested that
patients with mild to moderate depression would fare best in psychotherapeutic
treatments.
Moreover, the tendency to prescribe medications over other treatments stand in
contradiction with widely accepted recovery models that developed from the
consumer/survivor movement of the 1970’s (Davidson & Roe, 2007; Frese & Davis,
1997). The consumer/survivor movement, which established itself as a protest against the
over medicalization of psychiatric conditions and increased hospitalization, sought to
empower patients to choose their own path towards recovery. There are multiple
definitions of recovery; however, Substance Abuse and Mental Health Services
Administration (SAMHSA, 2012) has developed a working definition, which
conceptualizes recovery as a holistic process and highlights the importance of hope,
respect, strengths and responsibility, and self-determination and direction. In addition,
recovery is holistic and culturally-based, and considers the importance of allies/peer
support, relationships/social networks, and could take multiple forms of interventions.
In addition, a recent meta-analysis of 34 studies on patient’s treatment preference
for anxiety, depression and other disorders in primary and specialty settings recorded that
psychological treatments were preferred over psychopharmacological treatments
(McHugh, Whitton, Peckham, Welge, & Otto, 2013). Also, Jorm (2012) recorded that
treatment choice changed with levels of perceived severity of the condition, starting with
self-help and moving towards professional help. Moreover, people’s preference for nonprofessional help is supported by empirical studies demonstrating the lifestyle
management (i.e. diet, exercise, and alcohol and smoking; Berk, Sarris, Coulson, &

4

Jacka, 2013), tai chi (Yin & Dishman, 2014; Wang et al., 2013), and social support
(Santini, Koyanagi, Tyrovolas, Mason, & Haro, 2015). It is evident that medical
professionals have a different practice than the suggested psychiatric guideline and
contemporary models of treatment and recovery, and heir patient’s treatment preferences.
What might account for these monolithic treatment recommendations in the face
of empirical findings and institutional guidelines? These changes in attitude may be
contextualized in the backdrop of social, historical, and institutional forces. For instance,
in 1989 George Bush and the American congress declared that the 1990s was “the decade
of the brain” (Miller, 2010), which prioritized the conceptualization of psychological
disorders using genetic and neurobiological models. Paralleling these changes was directto-consumer advertising for antidepressants, which between the year 1989 to 2003
increased from $12 million to over $3 billion (Kravitz et al., 2005; Rosenthal, Berndt,
Donohue, Frank, & Epstein, 2002). Researchers have found financial ties between the
psychopharmaceutical industry and members of the APA in charge of developing
treatment guidelines (Cosgrove et al., 2013). This evidence of an unaccounted conflict of
interest, and a possible explanation for the differences in international guidelines of
depression. In addition, the last three decades has seen an increase in conceptualizing
psychological problems as physical illnesses, which propagates the idea that all mental
health issues are diseases of the brain (Banner, 2013; Miller, 2010). These formulations
are present in public resources that aim to educate population on causal models of mental
illness.
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Questioning Causal Models of Mental Illness
In a widely distributed depression psychoeducational booklet (NIMH, 2011),
NIMH delineates a biopsychosocial causal model of depression stating that “most likely,
depression is caused by a combination of genetic, biological, environmental, and
psychological factors.” However, it further defines depressive illnesses as “disorders of
the brain,” and notes that “trauma, loss of a loved one, a difficult relationship, or any
stressful situation may trigger a [brain-based] depressive episode.” Such explanations
highlight that psychosocial factors work as triggers and not causes, implicitly reducing
the disorder to neurobiological factors and hereditability. Unfortunately, the NIMH
psychoeducational booklet, which includes an explicit statement that depressive illnesses
are “disorders of the brain,” contradicts the current biopsychosocial model widelyendorsed in psychiatry (Engel, 2012). The biopsychosocial model proposes that mental
illness have multiple predisposing factors that are biological, psychological, and/or social
in character. In the more refined understanding of the biopsychosocial model it is the
interaction between all these factors, and not one factor, that increases the susceptibility
to developing a psychological disorder.
Efforts to popularize the biological perspective of mental illness are well
intentioned, driven by the hope that this might result in more compassionate attitudes and
reduce stigma towards the sufferer by suggesting that the disease is beyond people’s
control (Angermeyer, Holzinger, & Matschinger, 2009; Bar Levav, 1976; Crocetti, Spiro,
& Siassi, 1971; Miller, 2010; Pescosolido, 2013). However, a recent international metaanalysis utilized population-based studies and implemented a time-trend analysis to
observe changes in attitudes towards individuals with mental illness across time
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(Schomerus et al., 2012). Results recorded that, across the world, aggressive
implementation of mental health literacy promotion programs based on the brain-disease
model has not reduced stigma for depression and schizophrenia; the level of stigma
towards individuals with mental illnesses has remained stable for the last 20 years, but
knowledge regarding mental illness and biologically based causal models has increased.
Given their ineffectiveness at reducing stigma, campaigns that perpetuate a one
factor causal model have come into question by the international community
(Angermeyer et al., 2009; Miller, 2010). Some researchers propose that biological
explanations of psychiatric disorders may generate negative attitudes towards people with
mental illness, because they imply that people with a disorder are essentially and
categorically different from “normal” people (see genetic essentialism and
neuroessentialism; Dar-Nimrod & Heine, 2011; Haslam, 2011). This notion might be
further catalyzed by a neglect of recent developments within the epigenetics and
neuroplasticity literature that have brought into question our ideas that genetics are
immutable blueprints and that the mature adult brain is unchangeable (Gregurek, 2012;
Zaman, 2010).
Moreover, causal explanations of mental illnesses have been shown to affect
perceptions of illness, stigma, prognosis, and treatment preferences. Using data from the
General Social Survey of a nationally representative samples, Phelan, Yang, and CruzRojas (2006) documented the effects of biological/genetic explanations for mental
disorders on participants who estimated the perceived effectiveness of treatment for
individuals represented in a vignette as having depression or schizophrenia. According to
the study’s results, no differences were found regarding treatment recommendations for a
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vignette character diagnosed with schizophrenia or depression. However, participants
who endorsed genetic causes to the disorder were more likely to recommend
hospitalization and psychiatric medication for the vignette character. Researchers
concluded that attributions of biological causal factors indicated that the problems were
seen as severe and chronic, which explains the endorsement of more invasive
interventions. In addition, biological causal explanations further reduced the participants’
optimism regarding the helpfulness of mental health professionals and the treatment that
those professionals provide.
Simialrly, Lam, Salkovskis, and Warwick (2005) compared participants’ general
attitudes towards mental illness and self-control skills across three experimental
conditions: biological, psychological, and control explanations of mental illness.
Participants were presented with a wide range mental illnesses, which included mood and
psychotic disorders. Participants were then presented with one of three causal
explanations: (1) a biological explanation that stated, “research suggests that these
biologically based disorders may be the result of genetic factors”; (2) a psychosocial
explanation that stated, “research suggests that these psychologically based problems
may be the result of environmental risk factors”; (3) and a control conditions that stated,
“research suggests that the causes of these disorders are not yet entirely clear.”
Researchers documented that participants in the biological condition perceived
individuals with a mental illness to be more disabled, less likely to be cured, more likely
to harm themselves, and more likely to need professional help and hospitalization in
comparison to individuals in the psychological condition. Lam, Salkovskis, and Warwick
(2005) findings highlighted the effects of causal models on mental illness perceptions;
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however, the study did not include the more prevalent biopsychosocial explanation (e.g.
research suggests that mental illness is caused by psychological, biological, and
environmental factors) used by most mental health care providers. In addition,
explanations regarding mental illness were reduced to a single factor (e.g., genetic vs
environmental), which do not represent the etiological nuances or complexity of mental
illness.
In a second experimental study, Deacon and Baird (2009) asked a sample of
undergraduates to imagine that they were experiencing major depression and assessed
their attitudes regarding the credibility of explanations, treatment efficacy, prognosis, and
self-stigma. The researchers experimentally manipulated the explanation of depression
provided to the participant—either a chemical imbalance (depression is medical illness
that is no different from any other disease and is caused by neurotransmitter imbalance)
explanation or biopsychosocial (depression is a common mental disorder with multiple
biological, psychological, and social causes) explanation. Their results recorded that
participants endorsed higher credibility of the biopsychosocial than chemical imbalance
explanation. Moreover, participants who received chemical imbalance explanations
reported on average less self-stigma compared to individuals in the biopsychosocial
condition.
However, participants who received the biopsychosocial explanations had more
positive perceptions of prognosis compared to the chemical imbalance explanation.
Participants who received chemical imbalance explanations perceived medication as the
most efficacious treatment. In contrast, participants in the biopsychosocial condition
perceived that changing one’s lifestyle and attitudes was the most efficacious treatment
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for depression. These trends were still present even after the researchers controlled for
pre-existing biochemical and psychosocial beliefs.
Deacon and Baird (2009) further claimed that causal explanations affect attitudes
towards mental illness and expectations regarding treatment. According to their findings,
causal explanations may have a priming effect on the receptivity of a particular treatment.
Caution should be taken when generalizing these results, however. The study relied
primarily on a sample of university students in abnormal psychology classes, which were
already exposed to theoretical models of depression. Moreover, while causal models of
mental illness are important at influencing treatment preferences, researchers failed to
consider the role of treatment psychoeducation and participant’s baseline attitudes
towards treatment in general.
Lam and Salkovskis (2007) studied the effects of causal beliefs of panic disorders
on psychotherapy treatment expectancies among individuals diagnosed with depressive
and anxiety disorders. Participants were presented with a video of a clinical interview for
a person who suffered panic attacks. Participants were placed into three different
conditions: biological or psychological explanation, or a control condition. The results
documented that, compared to the psychological explanation group, participants who
received biological explanations saw the person as less likely to progress in treatment,
more likely to need long term treatment, and at higher risk of harming self and others.
Unfortunately, results from this study are affected by the small sample size and limited
measures. However, these findings further contribute to understanding the effects of
biological explanations. Lam and Salkovskis’s (2007) study suggests that while
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biological causes seem to legitimize a disorder, they also seem to reduce the perceived
effectiveness of psychotherapy for individuals diagnosed with a mental illness.
Similar findings have been observed among a sample of participants who had
experienced and been diagnosed with depression. Kemp, Lickel, and Deacon (2014)
completed a study where participants were informed that a mouth swab test detected the
presence of chemical imbalances that lead to depression. Participants were placed in
either biological causes (presence of neurotransmitters being imbalanced) or control
condition (no imbalance detected). Participants in the chemical imbalance condition had
greater negative attitudes towards prognosis and lower negative mood regulation
expectancies in comparison to participants in the control condition. Self-stigma did not
differ between the conditions, which suggested that biological explanations might not
affect individuals’ levels of stigma; however, it did have a negative impact on
individuals’ perceived self-efficacy and possibility for recovery.
Moreover, participants in the control condition perceived both psychotherapy and
pharmacological therapy as credible forms of treatment, while participants in the
chemical imbalance condition only perceived pharmacological treatment as more credible
and effective than psychotherapy. These results confirm prior research indicating the
effects that biological causal explanations have on individuals’ expectancies.
Unfortunately, researchers did not include psychosocial and biopsychosocial explanations
in their study bringing to question whether providing such explanations might influence
their attitudes towards treatment.
It is evident that in the past few years there has been a growing interest in
understanding the effects of causal models of mental illness on illness perceptions,
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treatments outcome expectancies, and stigma. The general trends of these experimental
studies, along with population based research, seems to suggest that biological
explanations do not fully resolve the problem of stigma, and, in some instances, create a
lack of hope and negative treatment expectancies for evidence based psychotherapies.
Moreover, these causal models of mental illness seem to implicitly prime individuals to
accept certain treatments over others, and reduce their sense of control over their illness.
However, the acceptance of a particular treatment may be influenced by other factors
than etiological explanations. For instance, perceptions about one’s relation to treatment
may have effects on individuals desire to engage or expect positive outcomes of seeking
professional help.
Help-Seeking and Treatment Seeking Self- Stigma
Help-seeking theory suggests that the decision to seek help involves information
about symptoms, knowledge about resources, and the willingness to disclose the
problems to others (Rickwood et al., 2005). Overall, attitudes towards seeking treatment
have changed in the past four decades for the worse, particularly in regards to
psychotherapy. A cross temporal meta-analysis on attitudes towards seeking mental
health services among American university students culled studies from 1968 to 2008
that utilized the Attitudes towards Seeking Professional Psychological Help Scale—a
measure that emphasizes psychotherapy as a psychological treatment (Mackenzie,
Erickson, Deane, & Wright, 2014). The findings of the study suggested that in the last 40
years negative attitudes about seeking psychological treatments have increased among
this population. While the researchers note that attitudes regarding seeking treatment
(specifically psychotherapy) have changed, the studies included in the meta-analysis
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failed to account for participants’ preferences in treatment (e.g. medication versus
psychotherapy). Therefore, while treatment seeking attitudes towards psychotherapy have
become more negative this may not be the case for psychopharmacological treatment.
One way to understand changes in attitudes towards seeking treatment may be
related to the information that an individual has regarding different treatments and how
one is perceived by others for seeking such treatments. For instance, stigma (a barrier to
mental health care) has been found to lower people’s self-image, -esteem, -efficacy, and
willingness to seek treatment (Ben-Porath, 2002; Corrigan, 2004; Link & Phelan, 2001;
Vogel, Wade, & Haake, 2006). Public-stigma, the negative attitudes held by society
about individuals who have a mental illness, is positively related to self-stigma. It is
hypothesized that public-stigma leads individuals to internalize negative messages about
mental illness and see themselves through those negative lenses (Corrigan, 2004; Link &
Phelan, 2001; Vogel, Wade, & Hackler, 2007). A review of the literature that included
271 quantitative and qualitative studies on help-seeking and mental health related stigma
documented that individuals feared social judgment, rejection, ridicule, and
discrimination from others (Clement et al., 2014). Also, participants across studies
reported viewing people with mental illness as weak, crazy, lacking will power,
dangerous, not normal, different, unable to recover, unreliable, contagious, bad parents,
spiritually failing, and exaggerating and fabricating the illness; individuals who
internalized stigma (i.e., self-stigma) endorsed feeling of shame and embarrassment.
Tucker and colleagues (2013) documented that self-stigma is composed of two
constructs. In one hand, self-stigma is connected to having a mental illness and the
negative attributions made towards people of that group. One the other hand, self-stigma
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is associated to treatment seeking behaviors. Treatment seeking self-stigma results in
avoiding and foregoing seeking help as a way to decrease the possibility of being
stigmatized by others (Corrigan, 2004; Vogel et al., 2006).
Jennings and colleagues (2015) observed the effects of perceived stigma for
seeking treatment, self-stigma related to treatment seeking, and self-reliance on treatment
seeking behaviors among 246 college students. Using a mediated model they
demonstrated that individuals with greater perceived self-stigma for seeking treatment
(what others might think of them for seeking help) had higher self-stigma for seeking
treatment (a person’s attitudes towards themselves for seeking treatment), which in turn
was related to greater self-reliance and more negative attitudes towards seeking
treatment. These findings applied to participants with and without mental health
problems. However, participants who did not endorse mental health problems also had a
significant direct effect between self-stigma for seeking treatment and negative attitudes
towards seeking treatment. Individual who believed that others would judge them for
seeking treatment also held those self-stigmatizing attitudes toward themselves, which
impeded them from seeking help.
Exposure to Treatment Education
Multiple national mental health associations and institutions suggest that both
medication and psychotherapy are helpful in relieving depression. For instance, the
NIMH’s depression pamphlet (NIMH, 2011) states that, “For mild to moderate
depression, psychotherapy may be the best option. However, for severe depression or for
certain people, psychotherapy may not be enough”. Moreover, following a description of
medication treatment for depression the American Psychiatric Association claims that
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“Psychotherapy, or ‘talk therapy,’ is sometimes used alone for treatment of mild
depression; for moderate to severe depression, psychotherapy is often used along with
antidepressant medications.” Also, the American Psychological Association suggests
that “medications can be very helpful for reducing the symptoms of depression in some
people, particularly in cases of moderate to severe depression. Often a combination of
psychotherapy and medications is the best course of treatment.” Although these
American recommendations lie in contrast with those from the UK and Netherlands,
which correspond to the meta-analytic evidence on drug treatments and do not
recommend psychiatric medication for depression at all (Cosgrove et al., 2014), some
recommendation of both psychotherapy and medicine appears standard in the US.
Unlike psychopharmacological treatments that utilize direct-to-consumer
advertisements to educate their consumers, information regarding psychosocial
interventions do not reach the general population unless it is through educational
pamphlets, the health system, or through personal experience. Furnham (2009) in a
descriptive analysis of psychotherapy literacy documented that overall individuals have
optimistic views about the effects of psychotherapy. However, those who attended
psychotherapy were more likely to have realistic expectations of therapy and its
usefulness. Exposure to psychiatric treatment also has been found to reduce stigma
towards treatment (Schomerus, Matschinger, & Angermeyer, 2009). For those who have
not attended treatment, views of psychotherapy may be dependent upon other factors,
such as public opinion and media portrayals of mental health providers to understand
how such treatments work.
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In a study on the effects of television on help-seeking attitudes and stigma, Vogel,
Gentile, and Kaplan (2008) observed the relations between viewing comedy and drama
television shows and stigma towards seeking psychological treatment. The researchers
observed cultivation effects (Gerbner, 1969), or the strengthening effects of repeated
exposure to images and messages from television on people’s expectations and beliefs.
Their analysis utilized structured equation modeling to demonstrate the path relation
between these variables. The findings recorded that frequent exposure to comedy and
drama shows was related to increased stigma, which was related to less favorable
attitudes towards psychotherapy, and in turn to less willingness to seek help. In addition,
frequent exposure to drama and comedy shows was also related to less anticipated
benefits of disclosing information to a therapist and less favorable attitudes towards
psychotherapy and, in turn, less willingness to seek psychotherapy. Vogel, Gentile, and
Kaplan's (2008) study represents an important finding on the constructions of
psychotherapy and the possible affects that media has on attitudes towards psychotherapy
and their effect on treatment engagement. Unfortunately, this model did not account for
the exposure to mental health promotion programs or other psychoeducational
interventions nor did it account for other treatments such as medications.
Client Treatment Outcome Expectancies
Frank and Frank (1991) delineated the importance of individuals’ beliefs
regarding the healing properties of the practitioner. They proposed that clients’ faith and
hope in treatment results in psychotherapeutic gains may be attributed to placebo effects,
and not the psychotherapies themselves. Later on, research was conducted that
demonstrated that such claims were difficult to maintain as psychotherapy does not have
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a placebo quality (inert substance) in the same way that it does within physical health
research (Patterson, 1985). However, this finding does not annul the idea that
expectations of a treatment may have an effect on psychotherapy outcome.
Unlike the concept of hope and faith, client treatment expectancies are defined as
the client expectations regarding the process, client-therapist role, and outcome in
treatment. In particular outcome expectancies refers to the “expectations that therapy will
lead to change” (Arnkoff, Glass, & Shapiro, 2002, p. 335). The research of treatment
expectancies spans over a 50 year period, and the findings from the clinical and social
psychological literature have observed the trend that expectancies have major influences
in the client’s actual outcomes in and perceptions of treatment (Greenberg, Constantino,
& Bruce, 2006). Given such a long period of time several reviews have been conducted
regarding the effect of treatment expectancy and outcomes (Constantino, 2012; Dew &
Bickman, 2005; Glass, Arnkoff, & Shapiro, 2001; Greenberg et al., 2006; Noble,
Douglas, & Newman, 2001). In general expectancies have been divided into two types of
expectancies: (1) outcome of the treatment and (2) the role of the therapist and client.
Noble, Douglas, and Newman (2001) reviewed the literature regarding
expectation for pharmacological and psychotherapeutic treatments prior to the 1980s and
post-1980s (until 2001). Overall, their review noted an underlying trend regarding
outcome expectancies where clients were more likely to prefer and expect better
outcomes from psychological interventions or combination treatment (medication and
psychotherapy) in comparison to other interventions. However, severity of symptoms
were related to more favorable attitudes towards medication treatment. In addition,
positive expectations about treatment were related to better outcomes, particularly in
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studies conducted post-1980s, which asked clients to assess their own symptoms in
comparison to studies pre-1980s that relied on therapists’ assessments of their clients.
Similar findings have been observed across other reviews of treatment
expectancies that primarily involved psychotherapy as an intervention (Constantino,
2012; Dew & Bickman, 2005; Glass et al., 2001; Greenberg et al., 2006). Overall,
researchers across review studies indicated that expectancies were either positively
related to better treatment outcome or had no significant effect to outcome, suggesting
that the possible inclusion of treatment expectancies would either help or make no
difference rather harm clients. Tinsley, Bowman, and Ray (1988) reviewed the literature
related to experimental manipulations of clients’ expectations of psychotherapy. Their
findings suggest that the most helpful modes for changing client’s expectancies of
psychotherapy involved the use of videotape and audiotape material in comparison to
clinical interviews, verbal instructions, or printed material.
For instance, a study with 62 participants who were about to enter psychotherapy
treatment were placed in one of two conditions, a treatment orientation psychoeducation
or a control condition (Zwick & Attkisson, 1985). Participants in the treatment
orientation condition were shown an 11-minute video that included information about the
function of psychotherapy, clarification of client and therapist relationship, normalized
the initial discomfort of attending therapy, warned of clients avoidance of therapy after
difficult sessions, noted the slow and non-linear gains in psychotherapy, foreshadowed
that discomfort of discussing difficult topics, and provided general positive outcome
assessments of psychotherapy in reducing anxiety and depression. In comparison to their
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control group counterparts, participants in the orientation psychoeducation condition
demonstrated greater decrease in their initial symptoms at one-month follow-up.
Similar findings have been demonstrated in psychiatric consultations. Douglas,
Noble, and Newman (1999) showed a 10-minute video to participants who were going to
attend a psychiatric consultation. The video included information about the role of the
psychiatrist, role of the patient, causes of psychological problems, content of the
assessment interview, confidentiality, possible outcomes, issues concerning the stigma of
mental illness, and patients' fears of 'going mad' as well as a simulation of the
consultation process. In comparison to participants in the control condition, these patients
had more accurate expectations than those who did not view the video. The findings
imply that the there is an overall positive effect of introducing clients to information
about an encounter with psychiatrists. Both Douglas and colleagues (1999) and Zwick
and Attkisson (1985) provided substantial evidence supporting future clients’ preparation
for their encounters with psychiatric and psychological care providers. Unfortunately,
these studies are quite outdated and the psychological sciences have progressed in their
method of conceptualizing and treating psychological disorders. The fact that majority of
treatment expectancy studies have taken place between the 1960s and 1980s suggests that
the science of expectancies has been neglected in the past few decades.
Only a few contemporary studies have assessed the usefulness of including
expectancies producing or enhancing techniques. Jorm and colleague (2003) observed in
an Australian population based sample of depressed individuals the effect of different
psychoeducation interventions. In one condition, participants were provided with an
evidence based consumer guide about depression and its treatments versus a general
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pamphlet about depression. Their findings recorded that after a 6 month follow up
participants in the evidence based consumer guide viewed cognitive-behavior therapy,
electroconvulsive therapy, and the use of St. John warts for depression as more helpful in
comparison to other treatments. Unfortunately, researchers did not assess expectations or
how likely individuals were to seek a particular intervention, other than asking
individuals to rate how helpful different interventions might be. In addition, Jorm and
colleague (2003) did not find the effects of their intervention in comparison to control
due to small sample size of the intervention group
While there has been a neglect of treatment expectancies research since the 1980s,
recently there has been a resurgence in this area of research. In a pilot study of a 30
minute intake for CT with an expectancy enhancement (EE) protocol, Constantino (2012)
recorded a decrease in hopelessness and depressive symptoms among a small sample (n =
14) of depressed clients. The EE protocol included multiple pre- during- and reactive
during- treatment interventions such as tailoring CT rationale to clients’ problems,
delivering hope-inspiring messages, including expectancy-enhancing statements based on
clients’ strengths, increasing clients’ internal locus of control, and providing a nontechnical review of research on CT for depression. While these findings were promising,
the study utilized a small sample, and these participants already were seeking treatment
and therefore one cannot fully know the effects on motivation to seek treatment. In
addition, the EE protocol was created to enhance the reuptake of a particular
psychotherapy when multiple therapies have been found to be useful for depression
(Levant et al., 2006; http://www.div12.org/psychological-treatments/treatments/).
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In another contemporary mixed-method study of expectancy enhancement
interventions among older adults, Woodhead, Ivan, and Emery (2012) observed the
effects of inducing positive pre-therapy expectancies. The researchers provided patients,
who were recommended psychotherapy by their doctors, with standard psychotherapy
outcome data. The results demonstrated that participants who initiated psychotherapy
treatment viewed the outcome data as important in making their decision to initiate
therapy. Moreover, a qualitative analysis of interviews on participants’ exposure to
outcome data shared the theme that hopefulness of treatment success increased after
being provided with this information.
Overall, the expectancy outcome literature seems to suggest that describing the
process of therapy and helping clients have realistic expectation about treatment results
increases hopefulness and better treatment outcome as a whole. In addition, interventions
that provide standard information about psychotherapy seem to be good tools for
improving client’s attitudes and engagement with treatment. To date, no study has
observed whether providing psychoeducation to clients may have neutralizing effects
regarding the implicit treatment suggestions produced by etiological models of mental
illness. In other words, does providing patients with information about intervention undo
pessimistic outlooks upon treatment effects that they may hold due to causal models of
mental illness?
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CHAPTER 2
CURRENT STUDY
The purpose of the current study is to assess the effects of causal models of mental
illness (biological, psychosocial, biopsychosocial, and control) upon treatment
engagement and outcome expectancies beyond the effects of treatment psychoeducation
among adults in the general population. This aim will use a three-part experimental
vignette design where participants are asked to imagine what is like to be a character in a
vignette who is suffering from depression and decides to attend a doctor for help. A
vignette will be presented that describes a person with depression followed by the brief
illness perceptions questionnaire, perceived etiology of depression, psychotherapy and
medication outcome expectancies, treatment seeking self-stigma and treatment
engagement (Time 1—Baseline). In a second vignette, a doctor provides a depression
diagnosis as well as one of three forms of psychoeducation (a biological, psychosocial, or
biopsychosocial causal explanation) or no description of causes (i.e., a control condition).
Participants will be re-assessed on perceived etiology of depression, treatment seeking
self-stigma, psychotherapy and medication outcome expectancies, and treatment
engagement (i.e., self-reported perceived likelihood of engaging in psychotherapy,
medication, and non-professional help) in order to observe the effects of causal models of
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mental illness upon these outcome variables (Time 2—Psychoeducation). Afterwards, all
participants will be funneled into a third vignette, where the doctor provides treatment
psychoeducation regarding psychotherapy and medication. The third vignette will be
used to observe the effects of treatment psychoeducation on psychotherapy and
medication outcomes expectancies, and treatment engagement (Time 3—Treatment
education). Participants will be re-assessed on perceived etiology of depression, treatment
seeking self-stigma, psychotherapy and medication outcome expectancies, and treatment
engagement (i.e., self-reported perceived likelihood of engaging in psychotherapy,
medication, and non-professional help; see Appendix I for condition Flowchart).
Specific Aims and Hypothesis
Aim 1. What is the relation between illness perceptions (consequences, timeline,
concern, and emotional response) on attending psychotherapy and taking
psychiatric medication outcome expectancies at baseline?
a) Hypothesis: Illness perceptions of greater severity will have a positive relation to
positive outcome expectancies of medication and a negative relation to positive
outcome expectancies of psychotherapy.
Aim 2. What is the relation between illness perceptions (consequences, timeline,
concern, and emotional response) on treatment engagement at baseline?
a) Hypothesis: Illness perceptions of greater severity will have a positive relation to
medication engagement and negative relation to psychotherapy engagement.
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Aim 3. Does self-stigma of seeking treatment predict treatment outcome
expectancies (psychotherapy and medication) and treatment engagement at
baseline?
a) Hypothesis: Higher self-stigma of taking psychiatric medication will decrease
medication engagement and positive expectancies while increasing psychotherapy
engagement. Conversely, self-stigma of attending psychotherapy will decrease
engagement and positive expectancies of psychotherapy, and increase medication
engagement.
Aim 4. What is the effect of causal models of mental illness (biological,
psychosocial, biopsychosocial, and control) on perceived etiology of depression
(biological, psychological, and social) from Time 1 to Time 2?
a) Hypothesis: From Time 1 to Time 2, the biological causal model explanation will
increase endorsement of biological causes in comparison to psychosocial causal
model explanation and control condition. However, the biological causal model
explanation will decrease endorsement of social and psychological causes in
comparison to control condition, and psychosocial and biopsychosocial causal
model explanations.
b) Hypothesis: From Time 1 to Time 2, the psychosocial causal model explanation
will increase endorsement of psychological and social causes in comparison to
biological explanations and control condition. However, the psychosocial causal
model explanation will decrease endorsement of biological causes in comparison
to the control condition, and biological and biopsychosocial causal model
explanations.
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c) Hypothesis: From Time 1 to Time 2, the biopsychosocial causal model
explanation will increase endorsement of psychological and social causes in
comparison to the biological causal model explanation condition and control
condition. Also, the biopsychosocial causal model explanation will increase
biological causes in comparison to the psychosocial causal model explanation and
the control condition.
d) Hypothesis: From Time 1 to Time 2, the control condition will not change
endorsement of psychological, social, and biological causes in comparison to
biological, psychosocial, and biopsychosocial explanations.
Aim 5. What is the effect of causal models of mental illness (biological,
psychosocial, biopsychosocial, and control) on treatment engagement (i.e., selfreported perceived likelihood of engaging in psychotherapy and/or medication)
from Time 1 to Time 2?
a) Hypothesis: From Time 1 to Time 2, the biological causal model explanation will
increase medication engagement in comparison to psychosocial causal model
explanation and control condition. However, the biological causal model
explanation will decrease psychotherapy engagement in comparison to control
condition, and psychosocial and biopsychosocial causal model explanations.
b) Hypothesis: From Time 1 to Time 2, the psychosocial causal model explanation
will increase psychotherapy engagement in comparison to biological explanations
and control condition. However, the psychosocial causal model explanation will
decrease medication engagement in comparison to the control condition, and
biological and biopsychosocial causal model explanations.
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c) Hypothesis: From Time 1 to Time 2, the biopsychosocial causal model
explanation will increase psychotherapy engagement in comparison to the
biological causal model explanation condition and control condition. Also, the
biopsychosocial causal model explanation will increase medication engagement in
comparison to psychosocial causal model explanation and the control condition.
d) Hypothesis: From Time 1 to Time 2, the control condition will not change
medication and psychotherapy engagement comparison to biological,
psychosocial, and biopsychosocial explanations.
Aim 6. What is the effect of causal models of mental illness (biological,
psychosocial, biopsychosocial, and control) on treatment outcome expectancies (i.e.,
medication and psychotherapy) from Time 1 to Time 2?
a) Hypothesis: From Time 1 to Time 2, the biological causal model explanation will
increase positive outcome expectancies of medication in comparison to
psychosocial causal model explanation and control condition. However, the
biological causal model explanation will decrease positive outcome expectancies
of psychotherapy in comparison to control condition, and psychosocial and
biopsychosocial causal model explanations.
b) Hypothesis: From Time 1 to Time 2, the psychosocial causal model explanation
will increase positive outcome expectancies of psychotherapy in comparison to
biological explanations and control conditions. However, the psychosocial causal
model explanation will decrease positive outcome expectancies of medications in
comparison to the control condition, and biological and biopsychosocial causal
model explanations.
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c) Hypothesis: From Time 1 to Time 2, the biopsychosocial causal model
explanation will increase positive outcome expectancies of psychotherapy in
comparison to the biological causal model explanation condition and control
condition. Also, the biopsychosocial causal model explanation will increase
positive outcome expectancies of medications in comparison to psychosocial
causal model explanation and the control condition.
d) Hypothesis: From Time 1 to Time 2, the control condition will not change
positive outcome expectancies of medication and psychotherapy in comparison to
biological, psychosocial, and biopsychosocial explanations.
Aim 7. What is the effect of causal models of mental illness (biological,
psychosocial, biopsychosocial, and control) on self-stigma of seeking treatment (i.e.,
medication and psychotherapy)?
a) Hypothesis: From Time 1 to Time 2, the biological causal model explanation will
decrease self-stigma of seeking medication in comparison to psychosocial causal
model explanation and control condition. However, the biological causal model
explanation will increase self-stigma of seeking of psychotherapy in comparison
to control condition, and psychosocial and biopsychosocial causal model
explanations.
b) Hypothesis: From Time 1 to Time 2, the psychosocial causal model explanation
will decrease self-stigma of seeking psychotherapy in comparison to biological
explanations and control conditions. However, the psychosocial causal model
explanation will increase self-stigma of seeking medications in comparison to the
control condition, and biological and biopsychosocial causal model explanations.

27

c) Hypothesis: From Time 1 to Time 2, the biopsychosocial causal model
explanation will decrease self-stigma of seeking psychotherapy in comparison to
the biological causal model explanation condition and control condition. Also, the
biopsychosocial causal model explanation will decrease self-stigma of seeking
medications in comparison to psychosocial causal model explanation and the
control condition.
d) Hypothesis: From Time 1 to Time 2, the control condition will not change selfstigma of seeking medication and psychotherapy in comparison to biological,
psychosocial, and biopsychosocial explanations.
Aim 8. What are the effects of treatment education on treatment outcome
expectancies (psychotherapy and medication), self-stigma of seeking for seeking
treatment (psychotherapy and medication), and attitudes towards treatment
engagement (i.e., self-reported likelihood of engaging in psychotherapy, medication,
or psychotherapy and medication) between causal model explanations between
Time 2 and Time 3?
a) Hypothesis: From Time 2 and Time 3, treatment education (psychotherapy and
medication) will reduce between-group differences between biological,
psychosocial, biopsychosocial, and control condition in regards to self-stigma of
seeking, treatment engagement, and treatment outcome expectancies.
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CHAPTER 3
METHODOLOGY
Participants
A total of 736 participants were collected from Reddit, Craigslist, Mturk, and the
UMass Boston student pool. After checking for fraudulent and international cases, 305
cases were removed resulting in 431 total cases. Of the 305 cases, 70 were participants
from outside the United States,. These cases were removed, because the study sought to
evaluate the effects of information regarding mental illness messages within the United
States. Fraudulent cases (n = 235) were identified using by completion time of the survey
(if it took less than 30 minutes to complete the typically 30- to 45-minute survey);
participant’s responses to check screening questions, such as “enter the word Red” and
“choose number three”; and duplicate IP addresses. Of the 431 cases used in the study, 20
were found to have data missing at random. The data was imputed utilizing Expectation
Maximization technique resulting in 431 complete cases. There was a balanced
distribution of participants into each condition. the biological explanations (n = 111,
25.8%), psychosocial explanations (n =107, 24.8%), biopsychosocial explanations (n =
105, 24.4%), and control (n = 108, 25.1%) conditions.
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The average age of the sample was 29 years old with a range of 18 to 74. The
sample was made up of 57% female (n = 247) and 42.5% male (n = 183), and one
participant identified as intersex (.2%). Participants endorsed a broad range of sexual
orientations which included heterosexual (n = 289, 67.1%), gay (n = 16, 3.7%), lesbian (n
= 9, 2.1%), bisexual (n = 57, 13.2%), queer (n = 10, 2.3%), questioning (n = 16, 3.7%),
asexual (n = 29, 6.7%), and pansexual (n = 3, .7%) Moreover, the sample included a
diverse group of participants in relation to race and ethnicity. The groups endorsed
included Alaskan Native/Native American/Indigenous (n = 4, .9%), Latino (n = 41,
9.5%), Asia (n = 41, 9%), Pacific Islander/Native Hawaiian (n = 3, .7%), White (n = 289,
67.1%), Black/African American (n = 31, 7.2%), Multiracial (n = 15, 3.5%), and Other (n
= 7, 1.6%).
Highest levels of education obtained was comprised of some high school (n = 12,
2.8%), high school graduate/GED (n = 56, 13.0%), some college (n = 161, 37.4%),
Associate’s degree (n = 49, 11.4%), Bachelor’s degree (n = 109, 25.3%), Master’s degree
(n = 39, 9.0%), and Doctoral/ Professional degree (n = 5, 1.2%). In regards to income,
participants reported that they made under $10,000 (n = 31, 7.2%), $10,001-$20,000 (n =
31, 7.2%), $20,001-$30,000 (n = 43, 10.0%), $30,001-$40,000 (n = 38, 8.8%), $40,001$50,000 (n = 59, 13.7%), $50,001-$65,000 (n = 37, 8.6%), $60,001-$75,000 (n = 48,
11.1%), $70,001-$80,000 (n = 23, 5.3%), $80,001-$100,000 (n = 31, 7.2%), over
$100,000 (n = 34, 7.9%), and Unsure/Prefer not to answer (n =56, 13.0%). The overall
sample could be described as diverse in regards to age, gender, income, and education
(see Table 1). However, it is important to note that a majority of the sample was White.
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A total of 192 (45%) participants were currently or in the past diagnosed with
depression. The remaining 245 (55%) participants responded never receiving a diagnosis
of depression. Participants who had a diagnosis of depression and those who did not were
evenly distributed across experimental condition (for cross tabulation see Table 2).
Moreover, 198 (46%) participants reported attending psychotherapy currently or in the
past. The remaining 232 (54%) reported never attending psychotherapy. Both,
participants who attended and did not attend psychotherapy, were evenly distributed
across experimental condition (for cross tabulation see Table 3).
Table 1.
Demographics of Sample
Demographic Variable
Participant per Conditions
Biological
Psychosocial
Biopsychosocial
Control
Sex
Female
Male
Intersex
Sexual Orientation
Heterosexual
Gay
Lesbian
Bisexual
Queer
Questioning
Asexual
Pansexual
Race/Ethnicity
Native American/Indigenous
Latino
Asian
Pacific Islander
White
Black/African American
Multicultural
Level of Education
Some high school
High School graduate/GED
Some College
Associate’s degree
Bachelor’s degree
Master’s degree
Doctoral/Professional degree
Income
Under $10,000
$10,001 - $20,000
$20,001 - $30,000
$30,001 - $40,000
$40,001 - $50,000
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n

%

111
107
105
108

25.8
24.8
24.4
25.1

247
183
1

57
42.5
.2

289
16
9
56
10
16
29
3

67.1
3.7
2.1
13.2
2.3
3.7
6.7
.7

4
41
41
3
289
31
15

.9
9.5
9
.7
67.1
7.2
3.5

12
56
161
49
109
39
5

2.8
13
37.4
11.4
25.3
9.0
1.2

31
31
43
38
59

7.2
7.2
10
8.8
13.7

$50,001 - $60,000
$60,001 - $70,000
$70,001 - $80,000
$80,001 - $100,000
Over $100,001
Unsure/Prefer not to answer

37
48
23
31
34
56

8.6
11.1
5.3
7.2
7.9
12

Table 2.
Cross tabulation for being or having been diagnosed with depression by experimental
condition
Are you or have you been
diagnosed with
depression by mental
health or medical
professional?
Yes
No
Total

Biological
Explanation
52
(27%)
59
(25%)
111

Psychosocial
Explanation
41
(21%)
65
(28%)
106

Biopsychosoci
al Explanation
47
(25%)
56
(24%)
103

Control
Condition
52
(27%)
55
(23%)
107

Total
192
(45%)
235
(55%)
431

Table 3.
Cross tabulation for ever having attended psychotherapy by experimental condition
Have you ever attended
psychotherapy?
Yes
No
Total

Biological
Explanation
50
(25%)
61
(26%)
111

Psychosocial
Explanation
58
(29%)
49
(21%)
106

Biopsychosoci
al Explanation
44
(22%)
61
(26%)
103

Control
Condition
46
(23%)
61
(26%)
107

Total
198
(46%)
232
(54%)
431

Procedures
Participants were presented with a demographic questionnaire. Then, participants
were presented with a vignette of a character experiencing depression at Baseline (Time
1), and asked to respond the illness perception questionnaire. The illness perceptions
questionnaire included consequences of the illness (consequences), timeline or duration
of the illness (duration), perceived personal control over the condition (control), concern
over the illness (concern), and emotional responses to the illness (emotional). In addition,
participants were asked to complete measures self-stigma for seeking help, outcome
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expectancies, and engagement questionnaires related to attending psychotherapy and
taking psychiatric medications as well as the perceived causal models of mental illness
scale.
Afterwards, participants were randomly assigned into one of four conditions of
depression psychoeducation (Time 2): (1) biological, (2) psychosocial, (3)
biopsychosocial, and (4) control. Each condition presented the participant with a vignette
of a doctor stating that the character in the initial vignette meets diagnostic criteria for
major depressive disorder. With the exception of the control condition, each condition
received a corresponding causal explanation of depression. Then participants were asked
to complete the self-stigma for seeking help, treatment outcome expectancies, and
treatment engagement questionnaire regarding psychotherapy and medication as well
perceived etiology of depression scale.
All participants were presented with a third vignette providing treatment
education about both psychotherapy and medication for depression, Treatment Education
(Time 3). Following the vignette, participants were asked to answer self-stigma for
seeking help, outcome expectancies, and treatment engagement in psychiatric medication
and psychotherapy (for flow chart of procedures see Figure 1).
Measures
Demographic information. Participants were asked for their age, sex (male,
female, or intersex), gender (man, woman, genderqueer, transgender, MtF, or FtM),
sexual orientation (heterosexual, gay/lesbian, bisexual, queer, other), race/ ethnicity
(Latino, non-Hispanic White, African American/Black, Asian/Asian-American), level of
education, income, place of birth, and years in the US.
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Treatment utilization and perceived helpfulness. A set of four questions were
designed for this study to assess participants’ utilization of psychological and psychiatric
services. Participants will be asked past and current utilization of psychotherapy and
medication treatments using dichotomous (yes or no) questions. In addition, they will be
asked about their perception of helpfulness for these treatments using a five-point Likert
scale ranging from 1 (very unhelpful) to 5 (very helpful). Participants also will be asked
using a dichotomous question, whether they have received a depression diagnosis.
Perceptions and attitudes towards mental illness. Participants’ perceptions
regarding the vignette character’s condition was assessed using a modified version of
The Brief Illness Perceptions Questionnaire (BIPQ; Broadbent, Petrie, Main, &
Weinman, 2006). The BIPQ provides a rapid assessment of emotional and cognitive
representations of illness. Each item represents one perception of the illness and these are
rated from 0 to 10. Items include: consequences (‘How much does your illness affect
your life?’), timeline (‘How long do you think your illness will continue?’), personal
control (‘How much control do you feel you have over your illness?’), identity (‘How
much do you experience symptoms from your illness?’), coherence (‘How well do you
feel you understand your illness?’), emotional representation (‘How much does your
illness affect you emotionally? Does it make you angry, scared, upset, or depressed)?’
and illness concern (‘How concerned are you about your illness?’). In the current study
items were modified to assess the vignette’s character condition rather than personal
illness. For instance, ‘How much does your illness affect your life?’ was modified to state
“If you were in Alex’s situation, how much do think this experience would affect your
life?” Items have been reported as psychometrically suitable for a range of illnesses

34

(Broadbent et al., 2006). Items 3, 4, and 7 are reverse coded—higher score on all items
reflects a more negative perception.
Causal Models of Mental Illness. Participants’ biopsychosocial causal models of
depression were assessed using the Perceived Etiology of Depression Scale (PEDS;
Okumura & Sakamoto, 2012). The scale measures lay beliefs about the causes and risk
factors of depression. Twelve items reflect a range of possible biological (‘chemical
imbalance in the brain’), psychological (‘poor self-esteem’) and social (‘family
breakdown’) explanations for depression. Respondents rated each question on a fivepoint Likert scale (0 = not a cause, 1 = rarely a cause, 2 = undecided as a cause, 3 = likely
to be a cause, 4 = a cause). Scores for each subscale ranged from 0 to 16, with higher
scores indicating the greater importance of a given possible explanation of depression. In
addition, an open-ended question was asked to assess the extent that culture influences
participant’s perceived etiology of depression. The question stated, “Do you think there
are aspects of your cultural background that influence your beliefs about causes of mental
illnesses? If so, please explain how this influence functions?”
Treatment Outcome Expectancies. The Credibility/Expectancy Questionnaire
(CEQ) —The Expectancy Rating Scale (ERS; Devilly & Borkovec, 2000) was used to
assess participants’ expectancies of psychotherapy and medication. The ERS is composed
of 3-items taken from Borkovec and Nau's (1972) outcome expectancies questionnaire.
One question, “How much do you really feel that therapy will help you to reduce your
symptoms?” is rated on a 9-point Likert scale (not at all to very much). Two questions
“By the end of psychotherapy, how much improvement do you think will occur?” and
“By the end of the therapy period, how much improvement do you really feel will
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occur?” are rated on a 0% to 100% scale. Three items are standardized and summed to
create an expectancy subscale, measuring the degree to which the patient expects to
improve from the treatment. The original questionnaire has high internal consistency
(0.89 for the Credibility subscale in the current sample), test-retest reliability, and validity
(Devilly & Borkovec, 2000). A duplicate set of three questions were modified in the
current study to assess for outcome expectancies of taking psychiatric medications.
Treatment Engagement. The likelihood of engaging in treatment was assessed
by asking participants, “If you were in Alex’s situation, how likely would you engage in
the following treatments.” The question was developed for the current study and it
applies to three forms of treatment: psychotherapy (ex. psychologist, counselor,
therapist), psychiatric medication (ex. antidepressants, antianxiety, etc.), and nonprofessional help (ex. talk to family and friends). Participants rated the likelihood of
engaging in each of these treatment using a Likert scale ranging from 1 (Extremely
unlikely) to 7 (Extremely likely).
Stigma. Participants self-stigma towards seeking treatment were measured using
the Self-Stigma of Seeking Help (SSOSH) Scale (Vogel et al., 2006). The SSOSH contains
10-items that assessed using a 5-point Likert ranging from 1 (strongly disagree) to 3
(agree and disagree equally) to 5 (strongly agree). The SSOH has demonstrated good
reliability (.91) and test–retest reliability (.72) along with good construct, criterion, and
predictive validity across multiple studies. For the current study, only five items that are
highly correlated to the total scale score were selected. The five items include: “If I went
to a psychotherapy, I would be less satisfied with myself” (r = .832); “I would feel
inadequate if I went to a psychotherapy for psychological help” (r = .808); “It would
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make me feel inferior to ask a therapist for help” (r = .802); “I would feel worse about
myself if I could not solve my own problems” (r = .771); and “Seeking psychological
help would make me feel less intelligent” (r = .769). A duplicate set of these items were
modified to reflect self-stigma of seeking medication treatment; for example, “I would
feel inadequate if I took psychiatric medication for psychological help.”
Vignettes. Three vignettes were presented sequentially to participants. The first
vignette was used to help the participant imagine experiencing symptoms of depression.
The second vignette provided participants with information regarding causes of
depression and the third provides information regarding its treatments. The first vignette,
presented at baseline (Time 1), was based upon a vignette developed for the Mental
Health Module of the General Social Survey (GSS; 1996). The vignette depicted a
fictitious character named Alex, who meets criteria for Major Depressive Disorder as
outlined by the DSM-5 (APA, 2013). The vignette described Alex’s depressive
symptoms, but did not state that he has depression.
The second vignette, presented at Depression Psychoeducation (Time 2), showed
a fictitious doctor providing to Alex a diagnosis of Major Depressive Disorder based on
DSM-5 criteria and information regarding the causes of depression. There are a total of
four forms of the vignette, which match the biological, psychosocial, biopsychosocial,
and control condition. The third vignette depicted a fictitious doctor providing
information regarding psychotherapy and medication treatment for depression. Both the
diagnostic and treatment information provided by the fictitious doctor is a composite
summary of information found in standard psychoeducation pamphlets and informational
websites on depression from the National Institute of Mental Health
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(https://www.nimh.nih.gov/health/topics/depression/index.shtml), the American
Psychological Association (http://www.apa.org/topics/depress/recover.aspx), and the
American Psychiatric Association (http://www.psychiatry.org/patientsfamilies/depression/what-is-depression). A copy of all measures and vignettes used in the
study can be found in Appendix II.
Data Analysis
Descriptive analyses were used in order provide information of the sample data
such as age, gender, sexual orientation, and race/ethnicity. These analyses were used to
screen the date for missing values and the presence of outliers. Missing data was imputed
utilizing Expectation Maximization technique. Verification of assumptions included
distribution of the data for kurtosis and skewness using Kolmogorov-Smirnov and
Shapiro-Wilk tests. Data was checked for sphericity using Levene’s test. Overall, data
was found to be normally distributed.
Predictive Analytics software (PASW) Version 17 (SPSS) was used to run all
analyses for this study. Pearson’s r correlations were used to assess Aims 1 and 2 to
explore the relation between illness perceptions (consequences, timeline, concern, and
emotional response) to attending psychotherapy and taking psychiatric medication
outcome expectancies and likelihood of engagement at baseline. A series of linear
regressions were used to test the predictive power of self-stigma for attending
psychotherapy and taking psychiatric medication on engagement and outcome
expectancies treatment.
Multiple repeated measures analysis of variance (RM-ANOVA) were used to
assess Aims 5 through 7. First, a 4 × 2 RM-ANOVA was used to observe between-group
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differences (explanatory models of mental illness) as well as within group difference
(baseline and depression psychoeducation) in regards to perceived etiological causes of
depression, treatment engagement, outcome expectancies, and self-stigma of seeking
treatment. In order to test the hypothesis within each of these aims, post-hoc tests and
contrast were used to observe time and groups differences regarding the outcome
variables.
A second 4 × 2 RM-ANOVA was used to asses Aim 8, that group difference
present in Time 2 (regarding self-stigma of seeking treatment, and engagement and
outcome expectancies of psychotherapy) will not be significant in Time 3. Multiple two
one-sided t-tests were used to assess equivalence between-groups at Time 3. The
equivalence tests assess whether mean differences fall into a confidence interval
predefined as theoretically representing equivalence (Walker & Nowacki, 2010). Given
the paucity of research in the area, a threshold of 10% different was utilized. Scores that
did not have a difference equal or smaller than 10% were considered practically
equivalent. Groups were considered equivalent, when both t-tests demonstrated that the
mean difference differed significantly from the threshold.
Dependent variables in the current study were tested to verify that they met the
assumptions of RM-ANOVA. There were not any univariate outliers in the data, assessed
by inspection of a boxplot for values greater than 1.5 box-lengths from the edge of the
box. There were not any multivariate outliers in the data as assessed using Mahalanobis
distance with a critical values of ± 3. Moreover, the homogeneity of covariances was as
assessed using Box's test of equality of covariance matrices (p = .90). Levene's test of
homogeneity of variance (p > .05). showed that there was homogeneity of variances.
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Dependent variables were not skewed with the exception of biological etiological beliefs
of depression, which was found to be negatively skewed at baseline (Time 1) and
depression psychoeducation (Time 2). This variable was transformed utilizing X2
transformation. Analyses were run with transformed and non-transformed variable and
yielded same results. Statistical analyses presented in the results section used the nontransformed variable. Pillai's criterion was used in RM-ANOVA, because it is
considered a more robust test for unequal covariance matrices (Olsen, 1976).
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CHAPTER 4
RESULTS
The rest of the section is structured so that sub-section provides the results for
each aims as set forth in the Aims Section. First, baselines statistic of all outcome
variables are presented under its own sub-section. Second, the results section presents a
set of exploratory aims, which include correlations of illness perception variables to
treatment engagement and outcome expectancies. In addition, exploratory aims include
assessing the predictive power of self-stigma for attending psychotherapy and taking
psychiatric medications on treatment engagement and outcome expectancies. Third, the
result section presents the analysis of experimental aims, which include statistics for four
of the outcome variables, perceived etiologies of depression (biological, psychological,
and social), treatment engagement (psychotherapy, psychiatric medications, and nonprofessional help), treatment outcome expectancies (psychotherapy and psychiatric
medications), and self-stigma for seeking treatment (psychotherapy and psychiatric
medications) in relation to assigned experimental condition (biological, psychosocial, and
biopsychosocial explanations, and control condition) from baseline (Time 1), after
depression psychoeducation (Time 2), and after treatment education (Time3).
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Baseline Statistical Analysis
Statistical analyses were conducted to assess group difference among conditions
on all outcome variables. Differences in perceived etiology of depression (biological,
psychological, and social), treatment engagement, treatment outcome expectancies, and
self-stigma for seeking treatment in relation to assigned experimental condition
(biological, psychosocial, biopsychosocial, and control conditions) were observed
utilizing a one-way ANOVA at baseline (Time 1). There were no significant differences
among experimental conditions in relation to biological, F (3, 427) = 1.729, p = .16,
social, F (3, 427) = .448, p = .72, and psychological, F (3, 427) = 2.609, p = .05, causes
of depression. Similarly, there were no significant group differences in regards to
likelihood of attending psychotherapy, F (3, 427) = .384, p = .76, taking psychiatric
medication, F (3, 427) = .887, p = .45, and seeking non-professional help, F (3, 427) =
.096, p = .96. In addition, there were not statistically significant differences among
conditions in relation to positive outcome expectancies for attending psychotherapy, F (3,
427) = .046, p = .99, and taking psychiatric medications, F (3, 427) = 2.016, p = .11.
While this initial analysis demonstrated that there was not a statistically significant
difference in outcome variables among the experimental conditions, it is important to
note that score on outcomes variables are not the same across conditions.
Aim 1. The relation between illness perceptions (consequences, timeline, concern,
and emotional response) on attending psychotherapy and taking medication
outcome expectancies at baseline (Time 1).
Pearson r correlations were used to assess the relation between illness perceptions
(consequences, timeline, personal control, emotional representation, and concern) on
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psychotherapy and medication outcome expectancies at baseline (Time 1). It was
hypothesized that there would be a positive relation between illness perceptions and
positive expectancies of taking psychiatric medications, and a negative relation between
illness perception and positive expectancies of attending psychotherapy. First, endorsing
that depression would affect a person’s life had a statistically significant weak positive
association with positive outcome expectancies of taking psychiatric medication (r =
.169, p = .01). Second, endorsing that depression would continue had a statistically
significant weak positive association with positive outcome expectancies of taking
psychiatric medication (r = .129, p = .01). Third, endorsing having more control over the
depression had a statistically significant weak positive association with positive outcome
expectancies of attending psychotherapy (r = .241, p = .01). Fourth, being concerned
about depression had a statistically significant weak positive association with positive
expectancies of taking psychiatric medication (r = .253, p = .01) and attending
psychotherapy (r = .184, p = .01). Fifth, thinking that the experience of depression
would affect you emotionally has a statistically significant weak positive association with
positive expectancies taking psychiatric medications (r = .137, p = .01) and attending
psychotherapy (r = .138, p = .01; for correlation matrix Table 2). The results indicated
that, counter to predictions, increases in multiple of illness perceptions aspects were
associated with increases in optimistic expectancies of seeking treatment and of taking
psychiatric medications. Increases in positive outcome expectancies towards taking
psychiatric medications were related to increased concern over depression, the perception
that depression would continue, and affect the person’s life and emotions. Moreover,
perceived control and concern over depression were related to increased positive outcome
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expectancies of attending psychotherapy. Only outcome expectancies of attending
psychotherapy was related to perceived greater control over depression. Overall, more
illness perception variables were related to taking psychiatric medication in comparison
to attending psychotherapy.
Aim 2. The relation between illness perceptions (consequences, timeline, personal
control, emotional representation, and concern) on treatment engagement at
baseline (Time 1).
Pearson r correlations were used to assess the relation between illness perceptions
(consequences, timeline, personal control, emotional representation, and concern) on
attending psychotherapy, taking medication, and seeking non-professional help at
baseline. First, endorsing that depression would affect a person’s life had a statistically
significant weak positive association with attending psychotherapy (r = .242, p = .01),
taking medications (r = .286, p = .01), and seeking non-professional help (r = .110, p =
.01). Second, endorsing that depression would continue had a statistically significant
weak positive association with attending psychotherapy (r = .112, p = .01) and taking
medications (r = .300, p = .01). Third, endorsing having more control over the depression
had a statistically significant weak negative association with taking psychiatric
medication (r = -.133, p = .01) and a positive association with seeking non-professional
help (r = .171, p = .01). Fourth, being concerned about depression had a statistically
significant weak positive association with attending psychotherapy (r = .362, p = .01),
taking medications (r = .274, p = .01), and seeking non-professional help (r = .222, p =
.01). Fifth, thinking that the experience of depression would affect you emotionally had
statistically significant weak positive association with attending psychotherapy (r = .281,
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p = .01) and taking medications (r = .202, p = .01; for correlation matrix Table 2). The
results demonstrated that increases in likelihood of seeking non-professional help were
positively related to increases in endorsing control and concern over depression.
Moreover, increases in likelihood of taking psychiatric medications were associated with
increased concern about depression, and that depression would continue, and affect a
person’s life and emotions. At the same time, taking psychiatric medications was
associated with decreases in the perceived controllability of depression. Moreover,
increases in endorsement in likelihood of attending psychotherapy were related to
increases in being concerned about depression, thinking that depression would continue,
affect a person’s life and emotions, and that person has control over depression.
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1
.500**
-.271**
.602**
.658**
.242**
.286**
.022
.169**
-.323**
.412**
.442**
.113*
.300**
-.077
.129**

2

-.105*
-.221**
.061
-.113**
.241**
.000

3

.653**
.362**
.274**
.184**
.253**

4

.281**
.202**
.137*
.138**

5

.386**
.569**
.274**

6

.111**
.614**

7

.396**

8

Table 4.
Correlation of Illness Perception and Treatment Outcome Expectancies
Consequence
Timeline
Personal Control
Illness concern
Emotional representation
Likelihood of attending psychotherapy
Likelihood of taking psychiatric medications
Positive expectancies of attending psychotherapy
Positive expectancies of taking psychiatric medications
Note: p <.05, p <.01

9

-
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Aim 3. Self-stigma for seeking treatment predictive of treatment outcome
expectancies (psychotherapy and medication) and treatment engagement
(psychotherapy and medication) at baseline (Time 1).
A series of hierarchical linear regressions were utilized to assess the predictive
power of self-stigma for taking psychiatric medication and attending psychotherapy on
treatment outcome expectancies at baseline (Time 1). Results demonstrated that selfstigma for seeking treatment accounted for some of the variance of the treatment
engagement and outcome expectancies variables.
Self-stigma for seeking treatment as predictor of positive expectancies of
attending psychotherapy. The first model, which included self-stigma for attending
psychotherapy on positive expectancies of psychotherapy (Model 1) was found to be
statistically significant, F (1, 429) = 49.106, p < .01 with R2 of 10.3% with an adjusted R2
of 10.1%. The addition of self-stigma for taking psychiatric medications (Model 2)
resulted in a statistically significant R2 increase of .012, F(1, 428) = 5.571, p = .02. The
full model, which includes self-stigma for attending psychotherapy and taking psychiatric
medication was statistically significant, F (2, 428) = 27.600 p < .01, with an R2 of 11.4%
and an adjusted R2 of 11%, see Table 3.
Table 5.
Summary of Hierarchical Regression for Types of Self-stigma as predictors of positive
expectancies of psychotherapy
Variable
Self-stigma for attending
psychotherapy
Self-stigma for taking psychiatric
medications
R2
F for change in R2

B
-4.51

Model 1
SE B
0.064

β
-.320**

.103
49.106**
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B
-.584

Model 2
SE B
0.085

β
-.415**

.180

0.076

.143**

.114
5.571**

Note: *p < .05. **p < .01.

Overall, the result of hierarchical regression supports the hypothesis that less selfstigma for attending psychotherapy would increase positive expectancies of attending
psychotherapy. Moreover, counter to what was predicted, less self-stigma for taking
psychiatric medication predicted positive expectancies of attending psychotherapy.
Self-stigma for seeking treatment as predictor of positive expectancies of
taking psychiatric medications. The first model, which included self-stigma for taking
psychiatric medications on positive expectancies of psychotherapy (Model 1) was found
to be statistically significant, F (1, 429) = 90.07, p < .01 with R2 of 17.4% with an
adjusted R2 of 17.2%. The addition of self-stigma for attending psychotherapy (Model 2)
did not result in a statistically significant R2 change, F(1, 428) = 5.571, p = .106. The full
model, which include self-stigma for attending psychotherapy and taking psychiatric
medication was statistically significant, F (2, 428) = 46.517, p < .01, with an R2 of 17.9%
and an adjusted R2 of 17.5%; see Table 4.
Table 6.
Summary of Hierarchical Regression for Types of Self-stigma as predictors of positive
expectancies of taking psychiatric medication
Variable
B
Self-stigma for taking
-.539
psychiatric medications
Self-stigma for attending
psychotherapy
R2
F for change in R2
Note: *p < .05. **p < .01.

Model 1
SE B
.057

.174
90.736**

β
-.417**

B
-.620

Model 2
SE B
.076

.136

.084

β
-.479**
.094

.179
2.620**

Overall, the result of hierarchical regression supports the hypothesis that less selfstigma for taking psychiatric medication increased positive expectancies of taking
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psychiatric medications. Moreover, counter to what was predicted less self-stigma for
taking attending psychotherapy was not related to attending psychotherapy.
Self-stigma for attending psychotherapy as predictor attending
psychotherapy. The first model, which included self-stigma for attending psychotherapy
on likelihood of attending psychotherapy (Model 1) was statistically significant, F (1,
429) = 84.424, p < .01 with R2 of 16.4% with an adjusted R2 of 16.2%. The addition of
self-stigma for taking psychiatric medications (Model 2) did not result in a statistically
significant R2 change, F(1, 428) = .702, p = .40. The full model, which include selfstigma for attending psychotherapy and taking psychiatric medication was statistically
significant, F (2, 428) = 42.534 p < .01, with an R2 of 16.6% and an adjusted R2 of
16.2%; see Table 5.
Table 7.
Summary of Hierarchical Regression for Types of Self-stigma as predictors of
attending psychotherapy
Variable
B
Self-stigma for attending
-.204
psychotherapy
Self-stigma for taking
psychiatric medications
R2
F for change in R2
Note: *p < .05. **p < .01.

Model 1
SE B
.022

.103
84.424**

β
-.406**

B
-.221

Model 2
SE B
.030

.022

.027

Β
-.438**
.049

.114
.702

Overall, the result of hierarchical regression supports the hypothesis that greater
self-stigma for attending psychotherapy would decrease the likelihood of attending
psychotherapy. Moreover, counter to what was predicted, there was no association
between self-stigma for taking psychiatric medication and likelihood of attending
psychotherapy.
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Self-stigma for taking psychiatric medication as predictor for taking
psychiatric medications. The first model, which included self-stigma for attending
psychotherapy on positive expectancies of `psychotherapy (Model 1) was statistically
significant, F (1, 429) = 21.35, p = .65 with R2 of 5.3% with an adjusted R2 of 5.0%. The
addition of self-stigma for taking psychiatric medications (Model 2) resulted in a
statistically significant R2 increase .22, F(1, 428) = .130.28, p < .01. The full model,
which include self-stigma for attending psychotherapy and taking psychiatric medication
was statistically significant, F (2, 428) = 80.661 p < .01, with an R2 of 27.4% and an
adjusted R2 of 27%; see Table 6.
Table 8.
Summary of Hierarchical Regression for Types of Self-stigma as predictors of taking
psychiatric medication
Variable
B
Self-stigma for attending
-.133
psychotherapy
Self-stigma for taking
psychiatric medications
R2
F for change in R2
Note: *p < .05. **p < .01.

Model 1
SE B
.027

.053
23.857**

β
-.230**

B
.107

Model 2
SE B
.032

β
.184**

-.326

.029

-.626**

.274
130.276**

Overall, the result of hierarchical regression show that more self-stigma for
attending psychotherapy predicted increase in taking medication. Moreover, as predicted
less self-stigma for taking psychiatric medication predicted greater likelihood of taking
psychiatric medications.
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Aim 4. Effect of causal models of mental illness (biological, psychosocial,
biopsychosocial, and control) on perceived etiology of depression (biological,
psychological, and social) from baseline (Time 1) to depression psychoeducation
(Time 2).
A RM-ANOVA was used to assess the difference among four conditions
(biological, psychosocial, biopsychosocial, and control condition) on perceived etiology
of depression, which include biological, social, and psychological causes between
baseline (Time 1) and after depression psychoeducation (Time 2). It was hypothesized
that perceived etiological causes of depression would be more highly endorsed within the
condition that provided education on that specific cause. For example, endorsement of
biological causes was expected to increase in the biological condition. In addition, it was
expected that there would be a decrease in the endorsement of causes that were unrelated
to the specific condition in comparison to the other conditions. For example,
psychological causes might increase in the psychosocial condition, but would decrease in
the biological condition. Also, it was predicted that control condition would have no
changes in the three perceived etiological causes of depression in comparison to other
groups. Results demonstrated that there was a statistically significant interaction effect
between baseline (Time 1) and after depression psychoeducation (Time 2) by condition,
F(9, 1281) = 5.561, p < .01, Pillai’s Trace = .113, partial, η2 = .038, and this held true for
social causes of depression, F(3, 427) = 10.024, p < .01, partial η2 = .066, and
psychological causes of depression, F(3, 427) = 4.51, p < .01, partial η2 = .031.
A follow-up repeated measures ANOVA was used to observe the main effects of
time for each condition. There was a statistically significant effect of time within the
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biological explanation condition on biological causes, F(1, 110) = 5.694, p = .019, partial
η2 = .049, psychological causes, F(1, 110) = 9.294, p < .01, partial η2 = .078, and social
causes, F(1, 110) = 12.099, p < .01, partial η2 = .099. Within the biological explanation
condition, endorsement of biological causes was greater after depression psychoeducation
was presented (M = 17.154, SE = 7.19, p = .02). In addition, after depression
psychoeducation (Time 2) there was a lower endorsement of psychological causes (M = –
1.067, SE = .350, p < .01) and social causes (M = –1.154, SE = .335, p < .01) in
comparison to baseline (Time 1). These results supported the hypothesis that biological
explanations will increase endorsement of biological causes and decrease social and
psychological causes of depression.
Moreover, there was only a statistically significant increase in the endorsement of
social causes (M = .877, SE = .238, p < .01) between baseline (Time 1) and after
depression psychoeducation (Time 2) for the psychosocial explanation condition, F(1,
106) = 41.138, p < .01, partial η2 = .114. There were no statistically significant changes
on social, psychological, and biological causes from baseline (Time 1) and after
depression psychoeducation (Time 2) in the control and biopsychosocial conditions.
Counter to the hypothesis, there were no changes in the biopsychosocial condition, which
was expected to increase endorsement of all perceived etiologies of depression across
time. However, as predicted, there were no statistically significant changes in the control
condition across time. Overall, the results found that changes between baseline and after
depression psychoeducation occurred, but only within the biological or psychosocial
conditions, which increased in their respective causes. The psychosocial condition only
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led to increases in the endorsement of social causes and not psychosocial causes,
however.
Aim 5. Effect of causal models of mental illness (biological, psychosocial,
biopsychosocial, and control) on treatment engagement (psychotherapy, medication,
and non-professional help) from baseline (Time 1) to depression psychoeducation
(Time 2).
A RM-ANOVA was used to assess the difference among four conditions
(biological, psychosocial, biopsychosocial, and control condition) across two different
time points, baseline (Time 1) and after depression psychoeducation (Time 2) on
likelihood of engaging in different forms of treatment. It was hypothesized that there
would be increases in the endorsement of engaging in treatments related to each
respective causal explanation of depression. For example, it was predicted that
participants in the psychosocial condition would endorse greater likelihood of attending
psychotherapy, but decrease their likelihood of taking psychiatric medication. It was
predicted that these change would be greater in the psychosocial condition in comparison
to other causal explanations. Results demonstrated a statistically significant interaction
effect between baseline (Time 1) and after depression psychoeducation (Time 2) by
condition, F(9,1281)= 2.552, Pillai’s Trace = .053, p < .01, partial η2 = .018. These
results applied to the outcome variables of likelihood of attending psychotherapy,
F(3,427)= 4.046, p < .01, partial η2 = .028, and seeking non-professional help, F(3,427)=
3.248, p < .01, partial η2 = .025.
A follow-up RM-ANOVA was used to observe the simple main effects of time
for each condition. Counter to the hypothesized effect that biological explanations would
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increase likelihood of taking psychiatric medication and decrease likelihood of attending
psychotherapy, results showed that within the biological explanation condition there was
only a statistically significant, F(1, 110)= 12.038, p < .01, partial η2 = .000, decrease in
the endorsement of using non-professional help (M = –.523, SE = .151, p < .01) between
baseline (Time 1) and after depression psychoeducation (Time 2). However, these
changes only occurred within the biological condition. As predicted, within the
psychosocial explanation condition there was a statistically significant, F(1, 106)= 9.505,
p < .01, partial η2 = .082, increase in the likelihood of attending psychotherapy (M =
.257, SE = .143, p < .01) between baseline (Time 1) and after depression
psychoeducation (Time 2), but there were no statistically significant decreases in the
likelihood of taking psychiatric medications. These changes occurred only within the
psychosocial explanation condition.
Moreover, as hypothesized, within the biopsychosocial explanations there was a
statistically significant, F(1, 104)= 16.110, p < .01, partial η2 = .134, increase in the
likelihood of taking psychiatric medications (M = .495, SE = .123, p < .01) between
baseline (Time 1) and after depression psychoeducation (Time 2), but not for attending
psychotherapy. Counter to the hypothesis that there will be no statistically significant
changes between baseline (Time 1) and after depression psychoeducation (Time 2)
regarding likelihood in treatment engagement within the control condition, there was a
statistically significant, F(1, 107)= 5.352, p = .02, partial η2 = .047, increase in the
likelihood of taking psychiatric medication (M = .315, SE = .136, p = .02) between
baseline (Time 1) and after depression psychoeducation (Time 2).
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A one-way ANOVA was used to observe the simple effects of condition on each
time point. The results showed that there was no statically significant group difference at
baseline (Time 1) for taking psychiatric medications, F(3, 427)= .887, p = .45, partial η2
= .006, attending psychotherapy, F(3, 427)= .384, p = .76, partial η2 = .003, and seeking
non-professional help, F(3, 427)= .096, p = .96, partial η2 = .001. In addition, there were
no statistically significant group difference after depression psychoeducation (Time 2) for
taking psychiatric medications, F(3, 427)= 1.61, p = .19, partial η2 = .011, attending
psychotherapy, F(3, 427)= 2.171, p = .91, partial η2 = .015, and seeking non-professional
help, F(3, 427)= 1.81, p = .14, partial η2 = .013. The results suggest that there were no
conditions that resulted in change that was greater in one condition than the other.
However, there were statistically significant changes from Time 1 to Time 2 within some
causal explanations. The biological condition resulted in decreases in the likelihood of
seeking non-professional help, the psychosocial condition had an increase in likelihood of
attending psychotherapy, the control and biopsychosocial conditions had increases in
taking psychiatric medications.
Aim 6. Effect of causal models of mental illness (biological, psychosocial,
biopsychosocial, and control) on treatment outcome expectancies (i.e., medication
and psychotherapy) from baseline (Time 1) to depression psychoeducation (Time 2).
A RM-ANOVA was used to assess the difference among four conditions
(biological, psychosocial, biopsychosocial, and control condition) between baseline
(Time 1) and after receiving depression psychoeducation (Time 2) on positive outcome
expectancies related to attending psychotherapy and taking psychiatric medications. It
was hypothesized that there would be increases in types positive outcome expectancies
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within forms of depression psychoeducation that corresponded to that form of treatment.
For example, biological explanation condition will lead to decreases in self-stigma for
taking psychiatric medications. Interaction effect between baseline (Time 1) and after
depression psychoeducation (Time 2) by condition was found to be statistically
significant, F(6,854)= 4.254, Pillai’s Trace = .058, p < .01, partial η2 = .029. This held
true only for positive expectancies of psychotherapy, F(3,427)= 7.528, p < .01, partial η2
= .05.
A follow-up RM-ANOVA was used to observe the simple main effects of time
for each condition. Counter to the hypothesized effect, there were no statistically
significant changes in positive expectancies of attending psychotherapy, F(1,106)= .014,
p = .905, partial η2 = .000, or taking psychiatric medications, F(1,106)= 12.321, p = .10,
partial η2 = .025, within the biological explanation. Also, counter to the hypothesis, there
was a statically significant increase in positive expectancies of attending psychotherapy,
F(1,106)= 5.516, p = .02, partial η2 = .049, but not for taking psychiatric medications,
F(1,106)= 4.067, p = .25, partial η2 = .012, in the control condition.
In contrast, there was a statistically significant increase in the psychosocial
condition between baseline (Time 1) and after depression psychoeducation (Time 2) in
the endorsement of positive expectancies of attending psychotherapy (M = 1.143, SE =
.341), F(1,106)= 11.236, p < .01, partial η2 = .096, and taking psychiatric medication (M
= .454, SE = .217), F(1,106)= 4.37, p =.04, partial η2 = .04. Also, there was statistically
significant increase in the biopsychosocial condition for the endorsement of positive
expectancies of attending psychotherapy (M = .579, SE = .250), F(1,104)= 5.361, p = .02,
partial η2 = .049. A one-way ANOVA was used to observe the simple effects of
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condition on each time point. There was no statistically significant difference between
groups at baseline (Time 1) and after depression psychoeducation (Time 2) for positive
expectancies of attending psychotherapy, F(3,427)= .797, p = .50, partial η2 = .006, and
taking psychiatric medications, F(3,427)= .216, p = .886, partial η2 = .002. Overall, the
results suggested that psychoeducation of depression did affect treatment outcome
expectancies. In particular, there were increases in positive outcome expectancies in the
control, biopsychosocial, and psychosocial conditions for attending psychotherapy. The
psychosocial condition was the only condition to lead to increased endorsement of
positive outcome expectancies of psychiatric medications.
Aim 7. Effect of causal models of mental illness (biological, psychosocial,
biopsychosocial, and control) on self-stigma of seeking treatment (i.e., medication
and psychotherapy).
A RM-ANOVA was used to assess the difference between four conditions
(biological, psychosocial, biopsychosocial, and control condition) across baseline (Time
1) and after receiving depression psychoeducation (Time 2) on self-stigma related to
attending psychotherapy or taking psychiatric medications. It was predicted that each
self-stigma would decrease within each respective causal explanation conditions. For
example, self-stigma for taking psychiatric medications would decrease in the biological
condition, but increase in the psychosocial condition. Results demonstrated that
interaction effects of time and condition, F(6,854)= .730, p = .63, Pillai’s Trace = .010,
partial η2 = .01, were not statistically significant. The findings suggest that particular
explanatory models of depression do not have a unique effect on reducing or increasing
self-stigma for seeking treatment.
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There were statistically main effects of time for Time, F(2,426)= 23.715, p < .01,
Pillai’s Trace= .100, partial η2 = .100. This was true for self-stigma for attending
psychotherapy, F(1,427)= 24.983, p < .01, partial η2 = .055, and self-stigma for taking
psychiatric medications, F(1,427)= 40.385, p < .01, partial η2 = .086. Moreover, there
were no statistically significant group differences for self-stigma for attending
psychotherapy, F(3,427)= .547, p = .815, partial η2 = .001, and self-stigma for taking
psychiatric medications, F(3,427)= .314, p = .651, partial η2 = .002. Overall, counter to
the hypothesized effect, self-stigma for taking psychiatric medications and self-stigma for
psychiatric medications appears to across time. These findings demonstrated that
different psychoeducation on causes of depression did not affect self-stigma, but rather
the exposure to information results in reduction of self-stigma for seeking treatment.
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N
431

431

431

431

15.26
(2.98)
12.38
(3.72)
13.05
(3.75)

Biological
Time 1
Time 2
M (SD) M (SD)
14.58
(3.47)
13.44
(2.82)
14.21
(2.99)

15.32
(2.98)
14.07
(2.98)
15.11
(2.71)

Psychosocial
Time 1
Time 2
M (SD)
M (SD)
14.81
(3.38)
13.81
(3.11)
14.23
(2.65)

15.30
(2.89)
13.40
(3.17)
14.58
(2.90)

Biopsychosocial
Time 1
Time 2
M (SD)
M (SD)
14.84
(3.23)
13.28
(3.34)
14.16
(3.21)

14.13
(3.54)
12.73
(3.81)
13.75
(3.28)

Control
Time 1
Time 2
M (SD) M (SD)
13.89
(3.83)
12.60
(3.68)
13.81
(3.30)

16.68
(4.69)
16..62
(4.98)

5.22
(1.7)
4.62
(1.9)
4.92
(1.7)
17.29
(4.80)
16.89
(5.19)

6.35
(3.43)
6.72
(3.83)

5.01
(1.62)
4.31
(2.0)
5.06
(1.8)
16.64
(5.01)
16.65
(5.03)

6.63
(3.61)
7.28
(3.87)

5.20
(1.6)
5.10
(1.7)
5.03
(1.6)
16.10
(4.41)
16.30
(4.67)

5.80
(2.91)
6.28
(3.33)

5.08
(1.6)
4.61
(1.8)
5.07
(1.7)
17.11
(4.80)
16.75
(5.00)

6.59
(3.61)
6.96
(3.52)

5.28
(1.5)
4.63
(1.8)
5.0
(1.7)

15.96
(4.88)
16.30
(4.77)

6.04
(3.11)
6.88
(3.76)

4.84
(1.9)
4.37
(2.0)
5.0
(1.8)

16.07
(4.45)
17.16
(4.79)

6.69
(3.17)
7.55
(3.70)

4.78
(1.7)
4.84
(2.0)
4.55
(1.7)

16.10
(4.29)
16.07
(4.46)

6.41
(3.18)
6.60
(3.54)

5.00
(1.6)
4.65
(1.9)
5.07
(1.6)

6.75
(3.13)
7.08
(3.59)

F= 10.02, p< .01, df = 3**

F= 4.51, p< .01, df = 3**

ANOVA results
F=5.561, p < .01
F= 5.69, p = .02, df = 3**

.066

.038

Effect
size
.038
.004

.010

.002

.015

.018
.050

.025

.028

.018
.007

F=1.394 , p =.244, df = 3

F=.246, p =.864, df = 3

F= .730, p = .63, df = 3

F= 2.175, p= .09, df= 3**

F= 7.52, p< .01, df= 3**

F=1.833, p =.01, df = 18

F=3.710, p =.01, df = 3**

F=.993, p =.396, df = 3

F=4.06, p <.01, df = 3**

F=2.552, p < .05, df = 9

Table 9.
Repeated Measures ANOVA for Effect of Depression Psychoeducation on Perceived Etiology, and Treatment Engagement,
Outcome Expectancies, and Self-Stigma
Outcome variable
Time x Condition
Biological causes
Psychological causes
Social causes
Time x Condition
Attending psychotherapy
Taking psychiatric medications
Seeking non-professional help
Time x Condition
Positive expectancies of
attending psychotherapy
Positive expectancies of taking
psychiatric medications
Time x Condition
Self-stigma for attending
psychotherapy
Self-stigma for taking
medications
Note: *p < .05. **p < .01.

Pillai’s
Trace
.113

.053

.076
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Aim 8. Effects of treatment education on treatment outcome expectancies
(psychotherapy and medication), self-stigma for seeking treatment (psychotherapy
and medication), and attitudes towards treatment engagement (i.e., self-reported
likelihood of engaging in psychotherapy, medication, or psychotherapy and
medication) between causal model explanations between Time 2 and Time 3.
The first RM-ANOVA was used to assess the difference among four conditions
(biological, psychosocial, biopsychosocial, and control condition) between depression
psychoeducation (Time 2) and treatment education (Time 3) on likelihood of treatment
engagement (medications, psychotherapy, and non-professional help). It was
hypothesized that there would be a no group difference between from Time 2 to Time 3,
and that all outcome variables would be equivalent when measured using TOST. Results
show that interaction effects between depression psychoeducation (Time 2) and treatment
education (Time 3) by group were not statistically significant, F(9,1281)= .730, p = .57,
partial η2 = .006. In addition, there were no statistically significant main effects group
difference for likelihood of attending psychotherapy, F(3,427)= 1.240, p = .30, taking
medications F(3,427)= 1.573, p = .20, or seeking non-professional help, F(3,427)=
1.738, p = .16. However, a follow-up repeated measure ANOVA showed a statistically
significant increase in taking psychiatric medication (M = .182, SE = .07), F(1,427)=
110.80, partial η2 = .206, p < .01, and decrease in seeking non-professional help (M = ˗
1.086, SE = .06), F(1,427)= 19.125, p < .01.
A second RM-ANOVA was used to assess the difference among four conditions
(biological, psychosocial, biopsychosocial, and control condition) between depression
psychoeducation (Time 2) and treatment education (Time 3) on treatment outcome
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expectancies for medications and psychotherapy. Interaction effects between depression
psychoeducation (Time 2) and treatment education (Time 3) by group were not
statistically significant, F(6,854)= 1.610, Pillai’s Trace=.016 p = .56, partial η2 = .008.
In addition, there were no statistically significant main effects of group difference for
positive outcome expectancies for attending psychotherapy, F(3,427)= .438, p = .73, and
taking psychiatric medications F(3,427)= .347, p = .79. However, a follow-up repeated
measure ANOVA showed a statistically significant increases across Time 2 to Time 3 in
positive outcome expectancies of taking medication (M = 1.341, SE = .128), F(1,427)=
110.80, partial η2 = .206, p < .01, and attending psychotherapy (M = 1.086, SE = .144),
F(1,427)= 56.88, partial η2 = .117, p < .01.
A third RM-ANOVA was used to assess the difference among four conditions
(biological, psychosocial, biopsychosocial, and control condition) between receiving
depression psychoeducation (Time 2) and treatment education (Time 3) on scores of selfstigma related to attending psychotherapy and taking psychiatric medication. Results
demonstrated that interaction effects between depression psychoeducation (Time 2) and
treatment education (Time 3) by group were not statistically significant, F(6,854)= .819,
Pillai’s Trace=.011 p = .55, partial η2 = .006. In addition, there were no statistically
significant main effects group difference for self-stigma for taking medications,
F(3,427)= 14.057, p = .570, and self-stigma for attending psychotherapy, F(3,427)=
11.260, p = .62. However, a follow-up repeated measure ANOVA showed a statistically
significant decreases in self-stigma of attending psychotherapy (M = -.383, SE = .082),
F(1,427)= 12.628, p < .01, and self-stigma of taking medication (M = -.263, SE = .074),
F(1,427)= 21.781, p < .01. Multiple two one-sided t-tests were used to assess that all
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outcome variables were equivalent using an interval that is within 10% margin of
difference. Two- One-sided T-tests showed that all conditions were within 10% margin
of difference, which suggest that all variables were equivalent after treatment education
(Time 3; see Table 1 for T-tests results).
Overall, the results showed that there was an increase in likelihood of taking
psychiatric medication and decreased likelihood of seeking non-professional help after
treatment education was provided. Also, time rather than condition accounted for
increased positive outcome expectancies in attending psychotherapy and taking
psychiatric medications, and decreased of self-stigma for seeking those treatments.
Finally, after treatment education there were not any group difference in regards to the
observed outcome variables. Also, the outcome variables were equivalent, that is, the
means of the outcome variables (e.g., likelihood of attending psychotherapy, taking
psychiatric medication, and seeking non-professional help; positive expectancies of
attending psychotherapy and taking psychiatric medications; self-stigma for attending
psychotherapy and taking psychiatric medications) were within the interval of
equivalence specified.
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Figure 1. Repeated measures ANOVA assessing difference between Time 1 and Time 2
among biological, psychosocial, biopsychosocial, and control condition on the
psychological subscale of the perceived etiologies of depression.
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Figure 2. Repeated measures ANOVA assessing difference between Time 1 and Time 2
among biological, psychosocial, biopsychosocial, and control condition on the biological
subscale of the perceived etiologies of depression
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Figure 3. Repeated measures ANOVA assessing difference between Time 1 and Time 2
among biological, psychosocial, biopsychosocial, and control condition on the social
subscale of the perceived etiologies of depression
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Figure 4. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition for
endorsing likelihood attending psychotherapy.
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Figure 5. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition for
endorsing likelihood of taking psychiatric medication

67

Figure 6. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition for
likelihood of seeking non-professional help.
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Figure 7. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition on
positive outcome expectancies of attending psychotherapy
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Figure 8. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition on
positive outcome expectancies of taking psychiatric medications
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Figure 9. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition on Selfstigma for attending psychotherapy
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Figure 10. Repeated measures ANOVA assessing difference between Time 1, Time 2, and
Time 3 among biological, psychosocial, biopsychosocial, and control condition on Selfstigma for taking psychiatric medications
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CHAPTER 5
DISCUSSION
The current study utilized an experimental vignette design that presented
participants with a fictional character that was experiencing depression followed by
psychoeducation on depression and two treatment modalities (psychotherapy and
psychiatric medications). The study attempted to test the effects of providing biological,
psychosocial, and biopsychosocial explanations as well as no explanation, on the
participants’ perceived etiology of mental illness, self-stigma for seeking treatment,
likelihood of treatment engagement, and positive outcome expectancies. In addition, the
current study attempted to record whether providing education about psychotherapy and
medications would “equalize” the differences produced by the models of mental illness.
Given the paucity of research on self-stigma for seeking treatment and illness perception
of depression, a set of exploratory aims included observing the relation to these variables
to treatment engagement and outcome expectancies.
The relations between illness perceptions on positive treatment outcome
expectancies
The first exploratory aim was to observe the association between the illness
perception of depression and positive outcome expectancies of treatment (taking
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psychiatric medications and attending psychotherapy). A limited number of studies have
observed illness perceptions of depression (see for review Baines & Wittkowski, 2013).
Four studies focused on illness perceptions of depression, and, of these four studies, one
was completed on Latino men, two on an all-female sample, and one in a primary care
sample. Overall, these studies recorded positive associations between treatment
engagement and utilization of coping strategies on each of the illness perception factors
(consequences, timeline, personal control, emotional representation, and concern). Unlike
previous studies, however, the current study is the first to use an adapted version of the
brief illness perception questionnaire (IPQ) and to include large and diverse sample.
The results of the current study showed that concerns about depression and
thinking that depression would have an emotional effect had a positive association with
optimistic outcome expectancies for both taking psychiatric medications and attending
psychotherapy Moreover, endorsing having more control over depression was only
positively associated with optimistic outcome expectancies of attending psychotherapy.
These results highlight that perceived control and outcome expectancies of psychotherapy
are highly correlated, and may be considered inseparable (Delsignore & Schnyder, 2007).
Moreover, it lends support to previous studies that have found that perceived control over
one’s self and situation was associated with more positive attitudes towards
psychotherapy and prognosis (Bohon et al, 2016; Gaudianoa, Hughesc, & Miller, 2013;
Lam, Salkovskis, and Warwick, 2005).
In addition, in the current study endorsing that depression would affect a person’s
life and that depression would continue was positively associated with likelihood of
taking psychiatric medications only. These results support previous findings that people
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who perceive depression as chronic adhere to antidepressant treatment (Brown et al.,
2001). Previous studies also have shown that severity of the depression is associated
with endorsement of medication and hospitalization as fruitful treatments (Phelan, 2005;
Phelan, Yang, & Cruz-Rojas, 2006; Wright, Jorm, Harris, & McGorry, 2007). Overall,
the findings suggest that a sense of control over depression is connected with a more
positive expectancy of psychotherapy; however, depression that is perceived as more
persistent and having a greater impact in an individual’s life appears to be associated with
more positive attitudes towards psychiatric medications. In addition, these findings
underscore the importance of highlighting to patients that they can have control over their
condition and situation. Normalizing the patient’s experience by providing information
regarding the prevalence of depression. In addition, showing research that documents
increased wellbeing may be achieved with lifestyle changes, psychotherapy, and/or
antidepressants may result in decreases over concerns about the impact that depression
has on their lives.
The relations between illness perceptions on treatment engagement
The second exploratory aim of the current study was to observe the relation
between illness perceptions and likelihood of taking psychiatric medications and
attending psychotherapy. The findings suggest that being concerned about depression,
endorsing that depression would affect a person’s life, endorsing that depression would
affect a person emotionally, and endorsing that the experience of depression would
continue was positively associated with increased likelihood of attending psychotherapy
and taking psychiatric medications. These results further support Brown and colleagues’
(2001) findings that a positive association exists between seeking treatment and utilizing
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coping strategies based on perception of increased severity among patients in the primary
care setting. Moreover, these results suggest that believing that one has control over
depression was negatively associated with the desire to take psychiatric medications.
Similarly, to positive expectancies of attending psychotherapy, this adds to the existing
research that has suggested experiencing control over one’s condition may reduce the
likelihood of seeking medical treatments, such as psychiatric medications (Nieuwsma &
Pepper, 2010).
Overall, these results have implications for increasing the likelihood of treatment
engagement among mental health service consumers. For instance, it has been shown that
as perceived psychological distress of depression increases people are likely to seek
treatment beginning with self-help and continuing on to professional help (Jorm,
Griffiths, Christensen, Parslow, & Rogers, 2004). Given the results of the current study,
assessing patient’s views towards their depression and discussing the level of severity of
their condition may promote engagement in treatment. For example, reflecting to patients
how their depression affects their emotions and their life as well as how chronic and
concerning their depression is might result in increased positive expectancies and
likelihood of attending treatment. At the same time, providers should evaluate patient’s
perceived controllability over their depression in order to provide information about how
effective psychotherapy is in relieving depression. Also, they might suggest treatments
that the patient would have greater receptivity towards instead of primarily suggesting
psychiatric medications (Lawrence et al., 2012).
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Self-stigma of seeking treatment as predictor of treatment engagement and outcome
expectancies
The third exploratory aim observed the relation between self-stigma for seeking
treatment on treatment engagement and positive outcome expectancies. Unlike previous
studies, the current study observed the relation between self-stigma for seeking help and
two commonly used treatments of depression, attending psychotherapy and taking
psychiatric medications. A small percent of the variance in positive expectancies of
psychotherapy treatment was predicted by self-stigma for attending psychotherapy and
taking psychiatric medications. Moreover, increases in negative views of taking
psychiatric medications and decreases in negative views of attending psychotherapy were
found predict more positive expectations of attending psychotherapy. Moreover,
participants who had less negative views of themselves if they attended psychotherapy
endorsed greater likelihood of attending psychotherapy. These findings support the
documented association that less self-stigma for attending mental health treatment was
related to greater likelihood of seeking mental health services (Jenning et al., 2015;
Vogel, Wade, & Haake, 2006; Vogel, Wade, & Hackler, 2007). Moreover, in the current
study endorsing greater self-stigma for taking medications may have predicted seeking
psychotherapy, because using medications suggest that individuals may be addicted or
may become an addict (Interian et al., 2001; Read, Cartwright, Gibson, Shiels, &
Magliano, 2015).
Moreover, as expected participants who held more negative views for attending
psychotherapy and less negative views of themselves if they took psychiatric medications
endorsed greater likelihood of taking psychiatric medications. However, only less
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negative view of themselves if they took psychiatric medication were related to more
positive outcome expectancies of taking psychiatric medications. All together these
findings highlight the importance of including interventions that reduce stigma related to
treatment in order to promote positive expectancies and engagement in psychotherapy or
psychiatric medication.
Effects of causal models of depression on perceived etiological models of mental
illness
The fourth aim of the study was to observe the differences among the biological,
psychosocial, biopsychosocial, and the control condition on perceived etiologies of
depression. Unlike previous studies that have recorded participants’ beliefs in regards to
the credibility of different etiological explanations of depression (Kemp, Lickel, &
Deacon, 2014), the current study observed changes in the endorsed causes of depression
by the participants before and after the introduction psychoeducation of depression.
Overall, the hypotheses that different depression psychoeducation conditions would result
in increases of their respective etiological models and decreases in other models was not
supported. Also, the expectation that there would be statistically significant changes in
the biological, psychosocial, and biopsychosocial conditions in comparison to the control
condition was also not supported. However, results show that presenting participants with
an explanation that emphasizes a particular etiological cause does increase the belief that
that specific factor contributes more to depression across time within that experimental
condition.
Moreover, the results of the study seem to suggest that certain beliefs may be more
malleable than others. Participants who received biological causal explanations increased
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their endorsement of biological causal beliefs of depression and decreased their beliefs of
psychological and social causes. The biological condition was the only condition in
which there was reduction in endorsement about other causes of depression. The trend of
reducing beliefs in other causes after exposure to biological explanations may be a result
of the naturalistic fallacy and neuro-essentialist beliefs, or the belief that mental illness is
a biological “disease” that is determined by genetic factors to the exclusion of every other
cause, and that it is fixed and unchangeable (Phelan, 2005). In line with this
interpretation, Boyesen (2011) documented that providing biological explanations to
participants led to greater endorsement of essentialist beliefs of mental illness—that
disorder was fixed and immutable, in comparison to explanations that highlighted
freedom of choice.
Therefore, individuals who received the biological etiological explanation may reduce
their understanding exclusively to that one factor and believe it to be the only contributor
to their illness. In addition, the tendency towards seeing biological or genetic attributions
as essentialist and unchanging may be understood in the context of oversimplification of
genetic research for the general public (for a review see Dar-Nimrod & Heine, 2011).
Studies have recorded that the general public holds fatalistic attitudes in relation to
genetics and genetic explanations of their mental illness (Alper & Beckwith, 1993;
Easter, 2012).
Unlike biological causes, participants appeared to be more likely to increase their
endorsement of social and psychological causes when psychosocial explanations were
presented than when biological causal explanations were presented. In the current study,
psychosocial explanations included both social and psychological factors (i.e., loss of
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loved ones, poverty, pessimistic worldview, etc.), which may explain why these two
causes increased after exposure to psychosocial psychoeducation of depression. There
was not a reduction in the endorsement of biological causes after psychosocial
explanations were provided. The maintenance of biological endorsement may be
explained in the context of contemporary campaigns that promote biological causes of
mental illness (Schomerus et al., 2012) and the worldwide increase in knowledge related
to the biological model (Angermeyer et al., 2009; Miller, 2010). Participants may have
internalized that biology contributes to mental illness making it difficult to change these
beliefs with psychoeducation that only emphasizes psychosocial factors. In addition, the
maintenance of the endorsement of biological causes in the face of psychosocial
education might be because the psychosocial condition emphasized causal factors that
can be changed by behavior, life events, self-esteem, and worldview, and that cannot be
easily reduced to an unchanging “essence placeholders” such as genes (see Park et al.,
2015). Therefore, including information regarding neuroplasticity and epigenetics is
important to counter essentialist beliefs of the biological model (Lebowitz et al. 2013,
2015).
Moreover, counter to previous research that has shown that biopsychosocial
explanations produced increases in the belief that psychosocial factors that may cause and
contribute to depression (Deacon & Baird, 2009), the present study found that the control
and biopsychosocial causal explanation conditions had no effects on psychological,
social, and biological causal beliefs. While the biopsychosocial condition provided
explanations of the three factors known to produce mental illness, the control condition
provided no explanation, but described that “scientist do not adhere to any one as the sole
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predictor of depression”. In this case, the biopsychosocial explanation might have
provided too much information to participant, which may lead a cognitive overload for
the participant (Reutskaja & Hogarth, 2009), and the control condition may not prompt
thinking about any one etiological factor producing no statistically significant changes.
Also, the information of all three factors and no information about any of the factors
could similar result in no increase or decrease, because it suggested that all causal factors
of depression could be weighted equally.
All together these findings may be applied to psychoeducation that may promote
inclusivity of all factors that produce depression. In particular, avoiding the utilization of
explanations that emphasize purely biological causes to prevent the reduction to this one
factor. Without an explicit explanation to counter why the biological bias is erroneous
participants retained their biologicals beliefs, but did not increase them. The emphasis of
biopsychosocial factors maybe more beneficial to patients as these explanations do not
produce increases or decreases of one factor over the other.
Effects of causal models of depression on treatment engagement
The fifth aim of the study was to record the shifts in participants’ beliefs regarding
engaging in different forms of treatment, such as medication, psychotherapy, and nonprofessional help. To date, a handful of studies have observed difference in motivation to
engage in treatments among differing explanations of mental illness (e.g. Phelan, Yang,
& Cruz-Rojas, 2006). Previous studies have recorded that individuals who are presented
with biological explanations tended to increase their endorsement of psychiatric
medication and hospitalization as appropriate treatments in comparison to other
explanations (Kemp, Lickel, & Deacon, 2014). Moreover, biological explanations have
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been found to lead to endorsing greater likelihood of seeking help in comparison to other
explanations (Goldstein & Rosselli, 2003). At the same time, previous studies have found
statistically significant differences between the endorsement and preference of
psychosocial interventions and medications, with psychotherapy being endorsed as more
effective for the treatment of mental illness (Gaudianoa, Hughesc, & Miller, 2013; Prins
et al., 2008). At best, the state of the literature could be said to be in conflict.
The present study adds to, and stands in contrast, with some findings from previous
research. The biological explanation condition led to decreases only in the endorsement
of seeking non-professional help. Decrease in endorsing seeking non-professional help
could be a function of the increased perceived severity of the depression caused by
biological explanations (Phelan, 2005; Phelan, Yang, & Cruz-Rojas, 2006). Moreover,
another explanation for the decrease in endorsements for seeking non-professional help
may be that in the vignette the doctor that provided to the fictional character a diagnostic
label ‘major depressive disorder’, which is an official psychiatric diagnosis. The
utilization of diagnostic labels has been associated with perceiving mental illness as more
severe and requiring professional treatment (Wright, Jorm, Harris, & McGorry, 2007).
Also, the utilization of psychiatric labels may explain why participants in the
biopsychosocial explanations and control condition endorsed increased utilization of
medication after psychoeducation of depression was presented. The increased
endorsement of taking psychiatric medications within the biopsychosocial condition may
be an effect of the biological elements in the explanation along with the usage of
psychiatric labels. The biopsychosocial condition may have resulted in geneticization of
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depression, which may have led to the notion that the person did not have control over
their illness and therefore the best course of action would be medication.
Similarly, participants in the control condition may have used the psychiatric labels
and the fictional doctor in the vignette as the only way to make sense of the utility of
treatment, given that no other information was available to assess the severity of
depression. It is also possible that there were no increases in seeking non-professional
help across conditions, because there is an already existing skepticism towards nonprofessional treatment for psychiatric illnesses in the general public (Angermeyer,
Matschinger, & Riedel-Heller, 1999).
Furthermore, the psychosocial explanation increased the likelihood of endorsing
attending psychotherapy. These results add to previous studies that have found that
psychosocial explanation increase endorsement of positive expectancies of psychotherapy
Tompkins, K. A., Swift, J. K., Rousmaniere, T. G., & Whipple, J. L. (2016). Potentially
the psychosocial explanations reinforced existing beliefs about the best modes of
treatment for these individuals (Furnham, Ritchie, & Lay, 2016; Jorm, 2012). Moreover,
the psychosocial explanation included the following statement:
“Sometimes the circumstances involved in depression are ones over which
an individual has little or no control. At other times, however, depression
occurs when people are unable to see that they actually have choices and
can bring about change in their lives.”
The psychosocial explanation provides education about psychosocial factors that may
help “undo” the effects of reductive and deterministic effects that psychiatric labels that
suggest severity as people are primed to see that they have control over their condition.

83

The findings from the current study have multiple implications for
psychoeducation campaigns focused on causal factors of depression. Psychoeducational
campaigns should focus on psychosocial factors as these explanations of mental illness
increased the likelihood of endorsing attending psychotherapy, a treatment that has been
demonstrated to reduce depression. Future studies on causal beliefs of depression might
control for the utilization of psychiatric labels in order to differentiate the role of
psychoeducation versus the label. However, this might decrease external validity, given
that psychoeducation information is usually anchored in the discussion of a particular
psychiatric condition. Also, not all participants may have found psychotherapy,
psychiatric medications, or non-professional help to be viable treatment options, although
they are the most common treatment recommendations. Future studies might use openended questions that allow participants to generate their own possible treatments or
coping strategies.
Effects of causal models of depression on treatment positive outcome expectancies
The third aim of the study was to observe the effect of psychoeducation of
depression etiology on treatment outcome expectancies. Results indicate that biological
explanations did not increase positive expectancies of taking psychiatric medications or
attending psychotherapy. These results add to previous conflicting findings that
expectancies and beliefs about treatment follow the etiological model presented to the
individual (Brandon, Hughesc, & Miller, 2013; Deacon & Abramowitz, 2005; Iselin &
Addis, 2003; Kemp, Lickel, & Deacon, 2014).
Phelan, Yang, and Cruz-Rojas (2006) documented that, while biological
etiological models may lead people to endorse psychiatric intervention, it does not result
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in positive prognosis for mental illness. That is, individuals may be open to taking
psychiatric medications, but not believe that they would get better. Also, Deacon and
Baird (2009) have shown that individuals who received chemical imbalanced
explanations perceived depression as more chronic, in need of longer term treatment, and
with less likelihood of improvement in comparison to biopsychosocial condition.
Therefore, it could be possible that receiving biological explanations participants did not
perceive positive outcome from any form of treatment due to an expectation that the
condition would not improve. Also, this may explain why there was not an increase the
likelihood of attending in psychotherapy or taking medications.
In contrast, participants who received biopsychosocial explanations increased
their endorsement of positive expectancies of attending psychotherapy, and participants
who received a psychosocial explanation had increases in positive outcome expectancies
for taking psychiatric medications and attending psychotherapy. The increased
endorsement of taking psychiatric medication and attending psychotherapy because
participant in this condition who perceive their problem as being influenced by
psychological and social forces also tend to perceive more control over their condition
and not see themselves as categorically different from others (Lam, Salkovskis, and
Warwick, 2005). Also, participants within these experimental conditions may believe that
they could have control over their situation, and might be more open to multiple forms of
treatment as they may experience “a global sense” of control over a psychiatric condition.
That is unlike the biological explanations, which may leave individuals feeling that no
intervention could produce positive change.
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No changes were present in the control condition in regards to positive outcome
expectancies of psychotherapy or psychiatric medications. This lack of statistically
significant increase or decrease could be accounted by the lack of information related to
mechanisms involved in depression. This lack of information might have made it hard for
individuals to imagine or predict the utility of anyone treatment without a framework to
make sense of those treatments, and increase positive expectancies.
In the context of these findings, psychoeducational programs should focus upon
psychosocial factors that were found to promote positive expectancies for the more
commonly use treatments of depression, psychotherapy and psychiatric medications. In
particular, psychosocial explanations of depression should be provided to individuals
with mild to moderate depression as this would promote the utilization of psychotherapy,
a treatment that has been found to be helpful for his level of severity, and at the same
time maintain positive expectancies for taking psychiatric medications. Moreover, future
research may seek to observe whether the psychological construct of perceived control
over depression plays role in these positive outcome expectancies, as previous research
suggest that there a significant overlap between control expectancies and outcome
expectancies (Delsignore & Schnyder, 2007).
Effects of causal models of depression on self-stigma for seeking treatment
The fourth aim of the current study was to observe the effects of explanatory
models of depression on self-stigma for taking psychiatric medications and self-stigma
for attending psychotherapy. In the current study there were no difference among
conditions on self-stigma for attending psychotherapy or taking psychiatric medications
between baselines and after psychoeducation of depression was provided. That is, no one
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explanatory model produced statistically significant increase or decrease of self-stigma
for seeking treatment in comparison to the other.
The existing literature suggests that self-stigma of mental illness has been
positively associated with self-stigma for seeking treatment (Jennings et al., 2015).
Previous research has observed that mental illness self-stigma is affected by explanatory
models and noted that biological explanations were associated with having less control
and less self-blame over one’s condition (Deacon & Baird, 2009; Lebowitz, Pyun, &
Ahn, 2014; Lee, Farrell, McKibbin, & Deacon, 2016). The current study replicates
experimental research observing no statistically significant differences between
biological versus control conditions on self-stigma (Kemp et al., 2014). While there were
no statistically significant effects of causal models of depression on self-stigma for
seeking treatment, this study is the first to examine this question.
Moreover, it is important to note that even though no condition decreased or
increased self-stigma for seeking treatment more or less than another, there were changes
in regards to time. Both self-stigma for taking medication and attending psychotherapy
decreased from baseline and after psychoeducation of depression was presented to
participants. This decrease in self-stigma for seeking treatment may be accounted by the
utilization of psychiatric labels, a factor that was present across condition and which has
been found to be related to positive help-seeking attitudes (Wright et al., 2007). The finds
suggest that providing patients with information regarding depression may be enough to
create changes in self-stigma for seeking treatment. However, future research should
observe the effects of providing depression psychoeducation and treatment with and
without psychiatric labels.
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Effects of psychoeducation of depression and treatment education on positive
outcome expectancies, treatment engagement, and self-stigma for seeking treatment
The eight aim of the current study was to observe the effects of providing
treatment education to participants. To date, few studies have observed the effect of
providing treatment information and its effect on outcome expectancies, self-stigma for
seeking treatment, and treatment engagement (see for review Constantino, 2012; Dew &
Bickman, 2005; Glass et al., 2001; Greenberg et al., 2006). Moreover, the study
attempted to record whether equivalence existed among conditions on the different
outcome variables at Time 3. After treatment education was provided to participants there
were no interactions effects between time and condition, and there were no statistically
significant main effects of group differences across any of these outcome variables. There
were, however, main effects of time for all three outcome variables between depression
psychoeducation and treatment education.
First, there was an increase in likelihood of taking psychiatric medications and a
decrease in likelihood of seeking non-professional help between Time 2 and Time 3. The
demands characteristic of the experimental manipulation should be taken into
consideration. For instance, the reduction in endorsement of non-professional help may
have been due to the introduction of psychoeducation based solely within a professional
treatment context. Participants received education only about psychiatric medication and
psychotherapy, and therefore may have continued to perceive these established
treatments for psychiatric conditions as more acceptable than non-professional treatment.
This caveat is particularly important in light of mental health literacy research has
documented that individuals utilize self-help strategies for mild to moderate depression
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before seeking out professional help (Jorm, 2012). Also, of note is that different cultural
groups prefer non-professional help as first line of treatment (Caplan et al., 2012).
Second, there were increases in positive outcome expectancies of taking
psychiatric medication and attending psychotherapy. The observed increase of both
treatments may be best understood as a function of the explanation provided of the
treatment. Participants were told how both treatments worked and that these treatments
would help them. The increase of positive expectancies for both treatments further
replicated the existing literature of interventions that show that providing information in
written or audio-visual format leads to increases in positive expectancies for
psychotherapy and psychopharmacological treatment (Noble, Douglas, & Newman,
2001).
Third, there was a decrease in self-stigma for attending psychotherapy and taking
psychiatric medications. A review of recent research on self-stigma has demonstrated that
presenting psychoeducation of depression and its treatments leads to reduction in selfstigma (Mittal, Sullivan, Chekuri, Allee, & Corrigan, 2012). Most of the studies reviewed
observed changes across time and did not have a control condition. The findings of the
current study suggest that changes in negative attitudes regarding treatment occurred
regardless of condition. In other words, presenting information related to any causal
model of depression along with education about psychotherapy and psychiatric
medication results in a reduction of self-stigma for seeking those particular treatments
across condition. Moreover, in the current study all participants were presented with a
vignette of a character experiencing depression, and a vignette of doctor who provides a
diagnostic label and explanatory model of depression. Exposure to this information may
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explain why there was reduction in self-stigma across all groups, particularly as research
has demonstrated that contact with a mentally ill person and information about mental
illness produces decreases in stigma and self-stigma (Yanos, Lucksted, Drapalski, Roe, &
Lysaker, 2015).
Unfortunately, the changes could not be fully attributed to the presentation of
treatment education, because there were not any statistically significant changes between
groups before or after the psychoeducation manipulation, or before and after treatment
education. Essentially there were no difference between the conditions from baselines
and across time points, and no one condition demonstrated that a greater endorsement of
any particular outcome variable. Changes up to treatment education could be accounted
by the effects of exposure to any information about treatment or depression regardless the
etiological model.
Overall, the findings suggest that providing treatment information may lower selfstigma for seeking treatment, and that regardless of causal models presented to patients,
explanation of possible treatments of depression can increase positive expectancies of
treatment. Unfortunately, it cannot be concluded whether time or the actual inclusion of
treatment information helped, because it was beyond the scope of the current study to
observe whether or not treatment education would have an effect on the outcome
variables. Given the results of the current study, clinicians should provide treatment
information in a step-wise fashion in order to prevent the negative effects biological
factors, such as decreases in endorsement of non-professional help. Psychosocial
explanations, treatments, and interventions should be presented first, particularly if the
level of severity of the depression is within the mild to moderate range. However, if the
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patient does not respond to psychosocial treatments, or if the depression is severe, then
biopsychosocial explanations and treatments should be provided afterwards.
Clinical Implications
Etiological models of mental illness and health beliefs have a strong effect on
patient’s attitudes towards treatment and prognosis. Studies have demonstrated that
shifting psychoeducation and education about mental illness can successfully change
people’s attitudes and lead to behavioral change among Latinos (Cabassa et al., 2015). In
addition, research has shown that exposure to information about treatment, such as
advertising and mental health literacy that may include a list of symptoms, labels for
conditions, and treatment options, can promote the utilization of treatment (Gallo et al.,
2015; Schoumor et al., 2009). Moreover, changes in treatment expectancies have been
shown to improve treatment in outcomes, particularly psychotherapy and medication use
(see for examples, Constantino et al., 2011; Devilly & Borkovec, 2000). A review of
different passive (i.e., written, audio, or visual material) psychoeducation programs has
shown that providing information about symptoms of depression and existing
intervention lead to symptom improvement (Donker, Griffithsn, Cuijpers, Pim, &
Christensen, 2009).
Moreover, a great number of patients, estimated at ranging from 50% to 75%,
receive treatment for depression in a primary care setting (Bray, 2016). In general,
primary care is considered the point of entry for mental health treatment; therefore, it is
imperative that patients receive information regarding their diagnosis that helps cultivate
motivation to engage in treatment, hope about treatment and self-care practices, and
general openness to change that would help them in the road to recovery.
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Psychoeducation of depression in the primary care setting, including descriptions of
symptoms and causes, and information about life styles change (e.g. diet, sleep, self-help,
and exercises), psychotherapy, and pharmacological treatments, has been found to reduce
symptoms of depression (Casañas et al., 2012; Shin et al., 2014).
In addition, patient’s must not only be informed about possible treatments, they
must also be educated about side effects and the appropriate treatment for a given level of
severity. In relation to medications for depression, Lawrence and colleagues (2012)
recorded that over half of PCPs would prescribe medications to mildly depressed
patients. This is particularly problematic because a recent meta-analysis did not find
strong evidence for the benefits of prescribing antidepressants to patients who experience
sub-threshold depression and mild depression (Cameron, Reid, & MacGillivray, 2014),
and restricts the patient’s capacity to decide on other evidence-based treatments for
depression.
Moreover, Byng, Bury, and Weaver (2007) documented that close to half of
patients seeking consultation for depression believed that their physician omitted
information about antidepressant, in particular the side effects of antidepressants. The
omission of side of effects may lead to non-adherence and discontinuation of treatment
once these side effects become noticeable to the patient. Treatment adherence is a
problem for psychosocial treatments as well. For instance, one-third of patients offered
psychosocial treatments (psychotherapy, group therapy, and counseling) adhered to
treatment compared to half of the patients who adhered to medication when these
treatments were offered (Vuorilehto, Melartin, Riihimäki, & Isometsä, 2016). The high
number of nonadherence for professional treatments, highlight the need to provide
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information of non-professional treatments to patients as these practice have been shown
to be helpful stand alone treatments for mild depression and adjunctive treatments for
more severe levels of depression.

Figure 11. Summary of increases and decreases of all outcome variables from Time 1 to
Time 3.
The current study primarily focuses on the effects of causal explanations of
mental illness and did not control for the presence of diagnostic labels or whether listing
symptoms of depression might be helpful to present to participants. However, the current
study adds to the existing literature that has found that presenting information regarding
etiologies of depression is beneficial in changing expectancies and likelihood of
engagement in treatment. In particular, the presentation of psychosocial explanations led
to increased positive expectancies of attending psychotherapy and taking psychiatric
medications, increased the endorsement of likelihood of attending psychotherapy, and
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increased endorsement of social causes, while not reducing beliefs about other causal
models or treatments. Biological explanations, unlike psychosocial explanations,
decreased positive expectancies of non-professional treatments and psychotherapy,
decreased endorsement of other causal models of depression, and did not increase
positive expectancies of any treatment. The biopsychosocial and control condition only
produced increases in likelihood of taking medication and positive expectancies in
attending psychotherapy. In light of these findings a list of recommendations and
considerations for psychoeducation and mental health literacy is as follows:
Avoid providing patients purely biological explanations. Providing purely
biological explanations of mental illness appears to be unhelpful to patients and the
psychological and psychiatric community. This explanatory model reduces the belief that
other factors play a role in depression, creating difficulties for patient to perceive the
possibility of change from other treatments. Moreover, biological explanations do not
increase engagement or positive expectancies of taking psychiatric medications, rather
they reduce the likelihood of engaging in first line and adjunctive interventions
scientifically found to be helpful for depression, such as exercise, social support, and
psychotherapy. In the context of existing guidelines and research, patients who suffer
from mild to moderate depression have been shown to benefit most from lifestyle
changes and psychotherapy (Gelenberg et al., 2010). These patients may be potentially be
psychologically harmed by suggesting that there depression purely caused by biology,
because this unsubstantiated beliefs may result in shifting of attitudes and beliefs that
predisposes them to be unreceptive to helpful treatments (i.e., lifestyle change and
psychotherapy).
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A core recommendation of this study is reducing the use of phrases such as “brain
disorder”, “brain disease”, and “disorder of the brain” in informational pamphlets and
psychoeducation that is provided to mental health consumers. Instead, it may be best to
present biological factors, such as genes or neurotransmitters imbalances, as interacting
and changing with the environment (Gregurek, 2012; Zaman, 2010). Including
information regarding neuroplasticity and epigenetics may help towards this end. Prior
research on biological explanations that included information regarding neuroplasticity
and epigenetic factor, and that highlighted the malleability of the brain, reduced
prognostic pessimism and hopelessness that usually result from biological explanation
that do not present these factors (Lebowitz et al. 2013, 2015).
Highlight the significance of psychosocial causal factors as strong
contributors to depression. The existing literature suggests a receptivity for
psychosocial explanations and treatments from the general public (Hanson, Webb,
Sheeran, & Turpin, 2016; Jorm, 2000). In the current study, solely psychosocial
explanation increased the endorsement of social causes while not reducing other possible
explanatory factors. Moreover, psychosocial explanations increased likelihood in the
utilization of psychotherapy and did not produce a reduction in the endorsement of
initially believed to be helpful treatments. Therefore, psychosocial causal factors and the
reminder that patients have control over their condition not only promote a scientifically
proven efficacious treatment, but increase positive expectancies of psychotherapy
treatments (Dew & Bickman, 2005; Greenberg, Constantino, & Bruce, 2006)
Moreover, highlighting psychosocial factors in psychoeducation may increase
depressed individuals’ likelihood of engaging in psychotherapy, while not impacting
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attitudes towards utilization of adjunctive treatments such as psychiatric medications or
non-professional help. The prioritizing of psychosocial explanations is important, given
that given primary care physicians tend to prescribe medication as first line of defense,
and because studies have shown that an antidepressant prescription signal to patients that
their depression is more severe then they initially might have believed. The
recommendation of highlighting psychosocial factors is particularly important given that
existing depression treatment guidelines in much of the world promote utilization of
psychiatric medication only for severe cases of depression, if at all (Cosgrove et al.,
2014).
Reducing self-stigma for seeking treatment to promote positive expectancies
and treatment engagement. A review on existing interventions to reduce self-stigma for
individuals experiencing mental illness identified common elements across sets of
proposed interventions, which included psychoeducation about mental illness,
psychotherapy, and empowerment and improving self-esteem strategies (Mittal, Sullivan,
Chekuri, Allee, & Corrigan, 2012). In light of the findings in the current study, it might
be helpful that self-stigma interventions included as part of psychoeducation campaigns.
Indeed, psychoeducational interventions educate patients about mistaken beliefs related
to medications, such as medication addictiveness, have been shown to reduce negative
attitudes towards medications.
Moreover, including information about possible negative attitudes that patients
might hold about seeking treatments along with suggestions for particular treatments that
may reduce stigma, self-criticism, and negative self-evaluation (for a review of selfcriticism reduction strategies see Kannan & Levitt, 2013) should be provided to mental
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health consumers to reduce the self-defeating and stigmatizing attitudes. Moreover,
including the following statement in psychoeducation campaigns such as, “some people
fail to seek attend psychotherapy or take antidepressants, because they believe that people
would judge them or that something might very wrong with them”, may help reduce
stigma. Similarly, acknowledging that individuals may see themselves are
“psychologically weak” if they attend psychotherapy can lead to a discussion of selfstigma; explicit recognition of the existence of these thoughts along with a description of
psychotherapy may be helpful to reduce these cognition and negative emotional
responses.
Limitations and Strengths
The findings of the current study should be interpreted in the context of several
limitations. One, participants were recruited and completed the survey online. Online
sampling is a strength, because it provides access to a diverse group of participants from
the community. The sample was two-thirds White, which represents the actual
distribution of race and ethnicity in the US population, but cannot provide a deeper
understanding of the ways that other cultural, racial, and ethnic groups would have been
affected by the different depression psychoeducation conditions. Studies have shown that
different views of mental illness exist in other countries (Glazer et al., 2004), as well as
within the United States by different cultural groups (Caplan et al., 2012).
Two, the psychoeducation was presented in written media and therefore this may
prohibitive to individuals whose reading capacities were limited or who have preference
for visual media. Research has shown pamphlets with images and story lines in everyday
context influence people’s perceptions of mental illness and their help-seeking behaviors
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more than written material (Cabassa et al., 2015). In addition, this may explain why the
experimental manipulation might have failed to produce statistically significant changes
across time points between groups.
Three, the utilization of diagnostic labels within the experimental manipulation
might have affected the level of perceived severity of the fictional character by the
participants. This might have reduced the observed differences between groups on across
the analysis. Also, the psychoeducation vignette, which is a doctor providing information
to the fictional character about their condition, could have influenced participant’s
perception of depression.
There are notable strengths about the current study as well. First, the study was
vignette-based experiment, which elicited participants’ lay beliefs about depression and it
treatments by requesting participants to place themselves into the character situations.
This allowed for participants with no previous experience with depression or treatment to
report what they would do if they were in that situations. At the same time, it is important
to note that what the participants believed they might does not always translate to that
behavior.
Second, previous studies have utilized a credibility check of the manipulation,
that is whether the explanation provided was convincing and believable. This is the first
study to assess changes of endorsed causes of depression before and after experimental
manipulation and compare among different etiological explanations of depression. This
important as studies have found that individuals hold a variety of believes regarding
mental illness (Elliott, Maitoza, & Schwinger, 2012). Third, the current psychoeducation
vignette was modeled after commonly presented information from the National Institute
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of Mental Health, American Psychological Association, and American Psychiatric
Association websites. No study to date has adequately assessed the response of
participant’s who encounter information from these institutions. Fourth, unlike previous
studies (Jenning et al., 2015), the current study observed self-stigma for attending
psychotherapy and taking psychiatric medications, and their relation to outcomes
variables separately. The current study adds to the limited literature of treatment seeking
stigma. In particular, it exposes the complex relation between self-stigma for two
commonly used treatments for depression (i.e., psychotherapy and medication).
Future Research
There is a body of research that shows the way that people make sense of their
mental illness and how presenting different model of mental illness shifts their
perceptions of expectancies, treatments, and stigma. However, there are no qualitative
studies recording the way that people make sense of information that is contradictory to
their preexisting beliefs of mental illness. Future qualitative research, particularly in the
setting of focus groups, would be helpful to observe the ways that people understand
psychoeducation of depression and treatments.
Moreover, future research should focus on developing and testing the efficacy
psychoeducation that delineates the interaction between different causal factors. The
biopsychosocial model continues to be championed as the most inclusive explanation of
mental illness (Epstein, 2014). A possible solution to this problem is developing and
testing the effect of a psychoeducation campaign that delineates the interaction between
different causal factors rather than listing factors that contributed to mental illness. For
instance, biopsychosocial explanations of depression that might improve expectancies of

99

all forms treatments if they highlighted how the environment and behavior affects neural
wiring and how the environment affects gene expression (Gregurek, 2012; Zaman, 2010).
To date, multiple studies have observed the separately relation between psychiatric
labels and stigma, and explanatory models of mental illness on prognosis and other
outcomes (Jorm, 2012). Future research should observe the role of explanatory models of
mental illness on individual’s expectancies, perceptions of treatment, and treatment
stigma while controlling for the effects of psychiatric labels. Moreover, the current study
suggests that reduction in self-stigma for seeking treatment may be a function of
exposure to any information related to depression, psychiatric labels, and its treatments.
Future research is required to understand how wording and active stigma reduction
components may alter different forms of psychoeducation of depression and may affect
individual’s attitudes towards seeking treatment (Phelan, 2005).
Moreover, there is a growing body of literature expanding all the way back to 1960s
in regards to lay beliefs and explanatory models of mental illness among different
cultural group (see for a review Abdullah & Brown, 2011). However, few studies have
observed the receptivity of the current biopsychosocial explanations of mental illness by
these cultural groups. Future research studies should observe the impact of different
etiological models mental illness impact stigma, and treatment expectancies and
engagement among different cultural groups.
Conclusion
In conclusion, presenting psychoeducation of depression to participants can
change their view regarding perceived etiology of depression, treatment outcome
expectancies, and likelihood of treatment engagement. However, particular models of
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psychoeducation of depression, such as the biological and psychosocial do not appear to
not have positive effects on self-stigma for attending psychotherapy and or for taking
psychiatric medications. It appears what might be most important in relation to selfstigma for seeking treatment would be exposure to any type of information related to
depression and its treatments. Moreover, treatment education appears to contribute to the
time trend of reducing self-stigma, increasing likelihood of engaging in treatment, and
increasing endorsement of positive expectancies beyond the particular psychoeducation
model utilized. While all outcome variables appeared to have reached equivalence
defined 10% margin of difference, the current study could not fully substantiate the claim
that it was due to presentation of treatment education. These findings despite the context
of their limitations provide information and direction for the development of evidencebased psychoeducation for mental health service users by highlighting importance of
psychosocial factors to further promote positive expectancies and utilization treatments
that in accordance of with professional set guidelines for the treatment of depression.
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APPENDIX A
FIGURE 12. FLOWCHART OF EXPERIEMENTAL VIGNETTE DESIGN
Demographic information
Treatment Experiences
History of depression diagnosis

Depression Vignette
Brief Illness Perception
Perceived Etiology of Depression
Self-Stigma of Seeking Psychotherapy
Self-Stigma of Seeking Medication

Doctor Vignette
Biological
Explanation

Psychotherapy Outcome Expectancies
Medication Outcome Expectancies
Treatment Engagement

Doctor Vignette
Psychosocial
Explanation

Doctor Vignette
Biopsychosocial
Explanation

Treatment Engagement
Psychotherapy Outcome Expectancies
Medication Outcome Expectancies
Perceived Etiology of Depression

Psychotherapy and Medication Psychoeducation

Treatment Engagement
Psychotherapy Outcome Expectancies
Medication Outcome Expectancies
Self-Stigma of Seeking Psychotherapy
Self-Stigma of Seeking Medication
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Doctor Vignette
No Explanation

APPENDIX B
SAMPLE OF SURVEY
Demographic Information
1. Age:
2. Sex:
3. Gender:
4. Sexual Orientation:
5. Race\Ethnicity:
6. Income:
7. Education:
8. U.S.\foreign born
9. Years in the U.S.
10. Are you currently attending psychotherapy? Y/N
11. Have you ever attended psychotherapy? Y/N
12. Helpfulness of psychotherapy 1 – 5?
1 (Very unhelpful)- 2(unhelpful)-3(neutral)-4(helpful)-5(very unhelpful)
13. Are you currently taking medication for a psychological condition? Y/N
14. Have you ever taking medication for a psychological condition? Y/N
15. How helpful was (or is) taking medication 1 – 5?
1 (Very unhelpful)- 2(unhelpful)-3(neutral)-4(helpful)-5(very unhelpful)
16. Are you or have you been diagnosed with depression by mental health or medical
professional?
Center for Epidemiologic Studies – Depression Scale (Bohannon, Maljanian, &
Goethe, 2003)
(1) rarely or none
(2)
(3)
(4) most or all of
of the time (less
the time
than once a week)
17. I felt that I could not shake off the blues even with the help from my family or friends
18. I had trouble keeping my mind on what I was doing
19. I felt depressed
20. I felt everything I did was an effort
21. My sleep was restless
22. I enjoyed life
23. I felt sad
Depression Vignette (Time 1)
Read the following paragraph. As you read try to imagine that you were having the same
experience as the character in the story.
For the past two weeks Alex has been feeling really down. Alex wakes up in the morning
with a flat heavy feeling that sticks with him/her all day long. He/She isn't enjoying
things the way he/she normally would. In fact nothing gives him/her pleasure. Even when
good things happen, they don't seem to make Alex happy. He/She pushes on through
his/her days, but it is really hard. The smallest tasks are difficult to accomplish. He/She
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finds it hard to concentrate on anything. He/She feels out of energy and out of steam. And
even though Alex feels tired, when night comes he/she can't go to sleep. Alex feels pretty
worthless, and very discouraged. Alex family has noticed that he/she hasn't been
himself/herself for about the last month and that he/she has pulled away from them. Alex
just doesn't feel like talking.
As you answer the following remember to continue imagining that you were having
Alex’s experience.
The Brief Illness Perception Questionnaire (Broadbent et al., 2006)
24. If you were in Alex’s situation, how much do you think this experience would affect
your life?
0
1 2 3 4 5 6 7 8 9
10
No effect at all
Severely affects my life
25. If you were in Alex’s situation, how long do you think this experience would
continue?
0
1 2 3 4 5 6 7 8 9
10
A very short Time
Forever
26. If you were in Alex’s situation, how much control do you think you would have
over this experience?
0
1 2 3 4 5 6 7 8 9
10
Absolutely no control
Extreme amount of control
27. If you were in Alex’s situation, how concerned would you be about having this
experience?
0
1 2 3 4 5 6 7 8 9
10
Not at all concerned
Extremely concerned
28. If you were in Alex’s situation, how much do you think this experience would affect
you emotionally? (e.g., would it make you angry, scared, upset or depressed?)
0
1 2 3 4 5 6 7 8
9
10
Not at all affected
Extremely affected
emotionally
emotionally
Perceived Etiology of Depression Scale (Okumura & Sakamoto, 2012)
How important do you think these factors are causing Alex’s experience:
0
1
2 undecided
3 likely to be a 4 a cause
not a cause
rarely a cause as a cause
cause
29. Increase in workload (a)
30. Poor self-esteem (b)
31. Family history of depression (c)
32. Family breakdown (a)
33. Lack of willpower (b)
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34. Hormone imbalance (c) [Edited]
35. Isolation (a)
36. Nervous temperament (b)
37. Chemical imbalance in the brain (c)
38. Unemployment (a)
39. Negative thoughts (b)
40. Impact of chronic physical illness (c)
Treatment Engagement
If you were in Alex’s situation, how likely would you engage in the following
treatments?
1
2
3
4
5
6
7
Extremely
Extremely
unlikely
likely
41. Psychotherapy (ex. psychologist, counselor, therapist)
42. Psychiatric Medication (ex. antidepressants, antianxiety, etc.)
43. Non-professional help (ex. talk to friends, family; exercise)
Expectancy Questionnaire: Psychotherapy (Devilly & Borkovec, 2000)
44. If you were in Alex’s situation, how much improvement do you think will occur by the
end of psychotherapy?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
For this set, close your eyes for a few moments, and try to identify what you really feel
about psychotherapy and its likely success. Then answer the following questions.
45. If you were in Alex’s situation, how much do you really feel that psychotherapy will
help your experience?
1 not at all 2
3
4
5 somewhat 6
7
8
9 very much
46. If you were in Alex’s situation, how much improvement do you really feel will occur by
the end of psychotherapy?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Expectancy Questionnaire: Medication (Devilly & Borkovec, 2000)
47. If you were in Alex’s situation, how much improvement do you think will occur by the
end of psychiatric medication treatment?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
For this set, close your eyes for a few moments, and try to identify what you really feel
about psychiatric medications and its likely success. Then answer the following
questions.
48. If you were in Alex’s situation, how much do you really feel that psychiatric medications
will help your experience?
1 not at all 2
3
4
5 somewhat 6
7
8
9 very much
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49. If you were in Alex’s situation, how much improvement do you really feel will occur by
the end of psychiatric medication treatment?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Treatment Seeking Self- Stigma
Psychotherapy
50. If I went to a psychotherapy, I would be less satisfied with myself.
51. I would feel inadequate if I went to a psychotherapy for psychological help.
52. It would make me feel inferior to ask a therapist for help.
Medication
53. If I took psychiatric medications, I would be less satisfied with myself.
54. I would feel inadequate if I took psychiatric medications for psychological help.
55. It would make me feel inferior to take psychiatric medications.
Doctor Vignette (Times 2)
Alex decides to go to the doctor to get help. The doctor enters the room and sits down to
talk with Alex about what brought him/her in that day. Alex tells the doctor how they
are feeling. The doctor listens carefully to what Alex is saying and seems interested and
sympathetic. The doctor explains:
Biological Explanation Condition
It seems from your symptoms that you meet a diagnosis of major depressive disorder.
Depression is a common medical illness that is no different from any other disease.
Depressive illnesses are disorders of the brain. Longstanding theories about depression
suggest that important neurotransmitters—chemicals that brain cells use to
communicate—are out of balance in depression. The parts of the brain involved in
mood, thinking, sleep, appetite, and behavior appear different. Brain-imaging
technologies, such as magnetic resonance imaging (MRI), have shown that the brains of
people who have depression look different than those of people without depression. But
these images do not reveal why the depression has occurred and cannot be used to
diagnose depression. Some types of depression tend to run in families suggesting that
the disorder may be heritable. Scientists are studying certain genes that may make some
people more prone to depression.
Psychosocial Explanation Condition
It seems from your symptoms that you meet a diagnosis of major depressive disorder.
Depression is often a signal that certain mental, emotional and physical aspects of a
person's life are out of balance. Significant transitions and major life stressors such as
trauma, difficult relationships, death of a loved one, the loss of a job, and any stressful
situation may cause depression. Moreover, continuous exposure to violence, neglect,
abuse or poverty may make some people more vulnerable to depression. Other more
subtle factors that lead to a loss of self-identity or self-esteem may also contribute.
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People who are easily overwhelmed by stress, or who are generally pessimistic appear to
be more likely to experience depression. Sometimes the circumstances involved in
depression are ones over which an individual has little or no control. At other times,
however, depression occurs when people are unable to see that they actually have
choices and can bring about change in their lives.
Biopsychosocial Explanation Condition
It seems from your symptoms that you meet a diagnosis of major depressive disorder.
Depression is often a signal that certain mental, emotional and physical aspects of a
person's life are out of balance. Depression is caused by biological, psychological, social
factors, and their interaction. Biological theories about depression suggest that important
neurotransmitters—chemicals that brain cells use to communicate—are out of balance in
depression. Brain-imaging technologies, such as magnetic resonance imaging (MRI),
have shown that the brains of people who have depression look different than those of
people without depression. The parts of the brain involved in mood, thinking, sleep,
appetite, and behavior appear different. But these images do not reveal why the
depression has occurred and cannot be used to diagnose depression. Some types of
depression tend to run in families suggesting that the condition may be heritable.
Moreover, significant transitions and major life stressors such as trauma, difficult
relationships, death of a loved one, the loss of a job, and any stressful situation also may
cause depression. Continuous exposure to violence, neglect, abuse or poverty may make
some people more vulnerable to depression. Other more subtle factors that lead to a loss
of self-identity or self-esteem may also contribute depression. People who are easily
overwhelmed by stress, or who are generally pessimistic appear to be more likely to
experience depression. Overall, some genetics research suggests that risk for depression
results from the influence of several genes acting together with environmental or other
factors. Sometimes the circumstances involved in depression are ones over which an
individual has little or no control. At other times, however, depression occurs when
people are unable to see that they actually have choices and can bring about change in
their lives.
Control Condition
It seems from your symptoms that you meet a diagnosis of major depressive disorder.
There are many competing theories about what causes depression. No one theory has
been established that provides all the answers.
Taking into account Alex’s condition and the doctor’s explanation of major depressive
disorder answer the following questions:
Expectancy Questionnaire: Psychotherapy (Devilly & Borkovec, 2000)
56. If you were in Alex’s situation, how much improvement do you think will occur by the end of
psychotherapy?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100
%
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For this set, close your eyes for a few moments, and try to identify what you really feel about
psychotherapy and its likely success. Then answer the following questions.
57. If you were in Alex’s situation, how much do you really feel that psychotherapy will help your
experience?
1 not at all 2
3
4
5 somewhat 6
7
8
9 very much
58. If you were in Alex’s situation, how much improvement do you really feel will occur by the end of
psychotherapy?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Expectancy Questionnaire: Medication (Devilly & Borkovec, 2000)
59. If you were in Alex’s situation, how much improvement do you think will occur by the end of
psychiatric medication treatment?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
For this set, close your eyes for a few moments, and try to identify what you really feel about
psychotherapy and its likely success. Then answer the following questions.
60. If you were in Alex’s situation, how much do you really feel that psychiatric medications will help
your experience?
1 not at all 2
3
4
5 somewhat 6
7
8
9 very much
61. If you were in Alex’s situation, how much improvement do you really feel will occur by the end of
psychiatric medication treatment?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Treatment Engagement
After hearing the doctor’s explanation, how likely would you be to engage in the
following treatments:
1
2
3
4
5
6
7
Extremely
Extremely
unlikely
likely
62. Psychotherapy (ex. psychologist, counselor, therapist)
63. Psychiatric Medication (ex. antidepressants, antianxiety, etc.)
64. Non-professional help (ex. talk to friends, family; exercise)
Perceived Etiology of Depression Scale (Okumura & Sakamoto, 2012)
After hearing the doctor’s explanations, how important do you think these factors are at
causing Alex’s experience:
0
1
2 undecided
3 likely to be
4 a cause
not a cause
rarely a cause as a cause
a cause
65. Increase in workload (a)
66. Poor self-esteem (b)
67. Family history of depression (c)
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68. Family breakdown (a)
69. Lack of willpower (b)
70. Hormone imbalance (c) [Edited]
71. Isolation (a)
72. Nervous temperament (b)
73. Chemical imbalance in the brain (c)
74. Unemployment (a)
75. Negative thoughts (b)
76. Impact of chronic physical illness (c)
Treatment Seeking Self- Stigma
Psychotherapy
77. If I went to a psychotherapy, I would be less satisfied with myself.
78. I would feel inadequate if I went to a psychotherapy for psychological help.
79. It would make me feel inferior to ask a therapist for help.
Medication
80. If I took psychiatric medications, I would be less satisfied with myself.
81. I would feel inadequate if I took psychiatric medications for psychological help.
82. It would make me feel inferior to take psychiatric medications.
Treatment Recommendation: Psychotherapy and Medication
Several types of psychotherapy—or talk therapy—can help people. Psychotherapy is a
collaborative treatment based on the relationship between an individual and a therapist.
Grounded in dialogue, it provides you a supportive environment that allows you to talk
openly with someone who’s objective, neutral and nonjudgmental. You and your
therapist will work together to identify and change the thought and behavior patterns
that are keeping you from feeling your best. Psychotherapy will help you understand
their condition, live happier, healthier and more productive lives. It helps people
develop effective coping strategies and habits; it teaches people tools to deal with stress
and unhealthy thoughts and behaviors. Psychotherapy helps patients manage their
symptoms better and function at their best in everyday life. By the time you’re done,
you will have solved the problem that brought you in, and you will have learned new
skills so you can better cope with whatever challenges arise in the future. There are
many different approaches to psychotherapy.
Antidepressants will help your condition primarily works on brain chemicals called
neurotransmitters, especially serotonin and norepinephrine. Other antidepressants work
on the neurotransmitter dopamine. Scientists have found that these particular chemicals
are involved in regulating mood, but they are unsure of the exact ways that they work.
All antidepressants must be taken for at least 4 to 6 weeks before they have a full effect.
You should continue to take the medication, even if you are feeling better, to prevent the
depression from returning. Medication should be stopped only under a doctor’s
supervision. Some medications need to be gradually stopped to give the body time to
adjust. Although antidepressants are not habit forming or addictive, suddenly ending an
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antidepressant can cause withdrawal symptoms or lead to a relapse of the depression.
Some individuals, such as those with chronic or recurrent depression, may need to stay
on the medication indefinitely.
Expectancy Questionnaire: Psychotherapy (Devilly & Borkovec, 2000)
83. If you were in Alex’s situation, how much improvement do you think will occur by the
end of psychotherapy?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
For this set, close your eyes for a few moments, and try to identify what you really feel
about psychotherapy and its likely success. Then answer the following questions.
84. If you were in Alex’s situation, how much do you really feel that psychotherapy will help
your experience?
1 not at all 2
3
4
5 somewhat 6
7
8
9 very much
85. If you were in Alex’s situation, how much improvement do you really feel will occur By
the end of psychotherapy?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Expectancy Questionnaire: Medication (Devilly & Borkovec, 2000)
86. If you were in Alex’s situation, how much improvement do you think will occur by the
end of psychiatric medication treatment?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
For this set, close your eyes for a few moments, and try to identify what you really feel
about psychotherapy and its likely success. Then answer the following questions.
87. If you were in Alex’s situation, how much do you really feel that psychiatric medications
will help your experience?
1 not at all 2
3
4
5 somewhat 6
7
8
9 very much
88. If you were in Alex’s situation, how much improvement do you really feel will occur by
the end of psychiatric medication treatment?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Treatment Engagement
After hearing the doctor’s explanation and treatment recommendations, how likely would
you be to engage in the following treatments:
1
2
3
4
5
6
7
Extremely
Extremely
unlikely
likely
89. Psychotherapy (ex. psychologist, counselor, therapist)
90. Psychiatric Medication (ex. antidepressants, antianxiety, etc.)
91. Non-professional help (ex. talk to friends, family; exercise)
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Treatment Seeking Self- Stigma
Psychotherapy
92. If I went to a psychotherapy, I would be less satisfied with myself.
93. I would feel inadequate if I went to a psychotherapy for psychological help.
94. It would make me feel inferior to ask a therapist for help.
Medication
95. If I took psychiatric medications, I would be less satisfied with myself.
96. I would feel inadequate if I took psychiatric medications for psychological help.
97. It would make me feel inferior to take psychiatric medications.
98. Do you think there are aspects of your cultural background that influences your
beliefs about causes of mental illnesses? If so, please explain how this influence
functions?
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APPENDIX C
TWO-SIDED T-TESTS OF EQUIVALENCE TABLE
Table 10.
Two-Sided T-tests of Equivalence
t-value for
t-value for
Outcome Variable
Mean
Lower
Upper
Lower CI
Upper CI
Compared to each condition
Difference
90% CI
90% CI
TOST
TOST
Attending psychotherapy
1 vs 2
0.16
-0.504
0.185
-48.727
47.196
1 vs 3
0.172
-0.525
0.180
-47.655
46.039
1 vs 4
0.195
-0.545
0.155
-48.080
46.242
2 vs 3
0.013
-0.369
0.343
-46.419
46.300
2 vs 4
0.035
-0.389
0.319
-46.830
46.500
3 vs 4
0.022
-0.385
0.340
-45.700
45.495
Taking Psychiatric Medications
1 vs 2
0.278
-0.114
0.670
-40.971
43.314
1 vs 3
-0.118
-0.506
0.270
-43.040
42.037
1 vs 4
0.174
-0.201
0.550
-43.245
44.779
2 vs 3
-0.396
-0.786
-0.006
-44.058
40.703
2 vs 4
-0.104
-0.480
0.273
-44.331
43.419
3 vs 4
0.292
-0.080
0.664
-43.088
45.681
Non-Professional Help
1 vs 2
-0.274
-0.666
0.117
-43.310
40.996
1 vs 3
-0.401
-0.778
-0.023
-45.511
42.006
1 vs 4
-0.445
-0.822
-0.067
-45.677
41.788
2 vs 3
-0.126
-0.529
0.277
-41.476
40.444
2 vs 4
-0.170
-0.573
0.233
-41.688
40.292
3 vs 4
-0.044
-0.433
0.345
-42.680
42.304
Positive Outcome Expectancies of
Attending Psychotherapy
1 vs 2
-0.130
-0.626
0.366
-33.730
32.866
1 vs 3
0.221
-0.275
0.717
-32.566
34.037
1 vs 4
-0.189
-0.658
0.280
-35.879
34.548
2 vs 3
0.351
-0.167
0.868
-30.815
33.054
2 vs 4
-0.059
-0.549
0.431
-33.900
33.501
3 vs 4
-0.410
-0.900
0.080
-35.103
32.339
Positive Outcome Expectancies of Taking
Psychiatric Medications
1 vs 2
-0.129
-0.545
0.287
-40.197
39.174
1 vs 3
0.017
-0.416
0.451
-38.041
38.172
1 vs 4
-0.135
-0.570
0.299
-38.536
37.509
2 vs 3
0.146
-0.292
0.584
-37.147
38.249
2 vs 4
-0.006
-0.446
0.433
-37.629
37.582
3 vs 4
-0.152
-0.609
0.304
-36.745
35.642
Self-Stigma for Attending Psychotherapy
1 vs 2
0.080
-0.587
0.748
-24.557
24.955
1 vs 3
0.244
-0.404
0.892
-24.862
26.106
1 vs 4
-0.229
-0.943
0.486
-23.639
22.582
2 vs 3
0.164
-0.506
0.834
-24.258
25.065
2 vs 4
-0.309
-1.046
0.428
-23.122
21.735
3 vs 4
-0.473
-1.193
0.247
-24.030
21.861
Self-Stigma for Taking Medication
1 vs 2
-0.421
-1.217
0.376
-21.616
19.871
1 vs 3
0.235
-0.511
0.980
-21.629
22.668
1 vs 4
0.002
-0.778
0.781
-21.186
21.194
2 vs 3
0.655
-0.146
1.457
-19.263
21.964
2 vs 4
0.422
-0.411
1.255
-18.995
20.671
3 vs 4
-0.233
-1.017
0.551
-21.563
20.582
Notes: 1 = Biological Condition, 2 = Psychosocial Condition, 3 = Biopsychosocial Condition, 4 = Control Condition
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p-value for
lower TOST
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001

< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001

< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
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